National Health (Listing of Pharmaceutical Benefits) Instrument 2024
made under sections 84AF, 84AK, 85, 85A and 88 of the
National Health Act 1953
Compilation No. 3
Compilation date: 1 July 2024
Includes amendments: F2024L00825
Registered: 14 August 2024
This compilation is in 10 volumes
Volume 1: sections 1–24 and Schedule 1 (Part 1: A–C)
Volume 2: Schedule 1 (Part 1: D–K)
Volume 3: Schedule 1 (Part 1: L–P)
Volume 4: Schedule 1 (Part 1: Q–Z, Part 2), Schedules 2 and 3
Volume 5: Schedule 4 (Part 1: C4076–C9993)
Volume 6: Schedule 4 (Part 1: C10020–C12999)
Volume 7: Schedule 4 (Part 1: C13004–C13925)
Volume 8: Schedule 4 (Part 1: C13927–C14567)
Volume 9: Schedule 4 (Part 1: C14568–C15443, Part 2)
Volume 10: Schedules 5, 6 and Endnotes
Each volume has its own contents
About this compilation
This compilation
This is a compilation of the National Health (Listing of Pharmaceutical Benefits) Instrument 2024 that shows the text of the law as amended and in force on 1 July 2024 (the compilation date).
The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.
Uncommenced amendments
The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the Register for the compiled law.
Application, saving and transitional provisions for provisions and amendments
If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.
Editorial changes
For more information about any editorial changes made in this compilation, see the endnotes.
Modifications
If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the Register for the compiled law.
Self-repealing provisions
If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.
Contents
Schedule 5—Schedule equivalent groups of brands of pharmaceutical items
1 Schedule equivalent groups of brands of pharmaceutical items
Schedule 6—General statement for drugs for the treatment of hepatitis C
1 Criteria for eligibility for drugs for the treatment of chronic hepatitis C
2 Assessment of patient
3 Treatment regimens
Endnotes
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history
Endnote 5—Editorial changes
Schedule 5—Schedule equivalent groups of brands of pharmaceutical items
Note: See section 11.
1 Schedule equivalent groups of brands of pharmaceutical items
The following table sets out schedule equivalent groups and the brands of pharmaceutical items included in the groups, for the purposes of section 11.
Listed Drug | Schedule Equivalent Group | Form | Manner of Administration | Brand |
Abacavir with lamivudine | GRP-21981 | Tablet containing abacavir 600 mg (as sulfate) with lamivudine 300 mg | Oral | ABACAVIR/LAMIVUDINE 600/300 SUN |
Acalabrutinib | GRP-27509 | Capsule 100 mg | Oral | Calquence |
Acalabrutinib | GRP-27509 | Tablet 100 mg | Oral | CALQUENCE |
Acamprosate | GRP-22403 | Tablet (enteric coated) containing acamprosate calcium 333 mg | Oral | Acamprosate Mylan |
Acarbose | GRP-20709 | Tablet 100 mg | Oral | Acarbose Viatris |
Acarbose | GRP-20718 | Tablet 50 mg | Oral | Acarbose Mylan |
Aciclovir | GRP-22959 | Eye ointment 30 mg per g, 4.5 g | Application to the eye | ViruPOS |
Aciclovir | GRP-15446 | Tablet 200 mg | Oral | Aciclovir APOTEX |
Aciclovir | GRP-19838 | Tablet 800 mg | Oral | Aciclovir APOTEX |
Acitretin | GRP-19579 | Capsule 10 mg | Oral | Neotigason |
Acitretin | GRP-19580 | Capsule 25 mg | Oral | Neotigason |
Adalimumab | GRP-25059 | Injection 20 mg in 0.2 mL pre-filled syringe | Injection | Humira |
Adalimumab | GRP-25059 | Injection 20 mg in 0.4 mL pre-filled syringe | Injection | Amgevita |
Adalimumab | GRP-25060 | Injection 40 mg in 0.4 mL pre-filled pen | Injection | Adalicip |
Adalimumab | GRP-25058 | Injection 40 mg in 0.4 mL pre-filled syringe | Injection | Adalicip |
Adalimumab | GRP-25060 | Injection 40 mg in 0.8 mL pre-filled pen | Injection | Amgevita |
Adalimumab | GRP-25058 | Injection 40 mg in 0.8 mL pre-filled syringe | Injection | Amgevita |
Adefovir | GRP-28116 | Tablet containing adefovir dipivoxil 10 mg | Oral | APO-Adefovir |
Adefovir | GRP-28116 | Tablet containing adefovir dipivoxil 10 mg (S19A) | Oral | Adefovir Dipivoxil Tablets 10 mg (SigmaPharm Laboratories) |
Adrenaline (epinephrine) | GRP-22391 | I.M. injection 150 micrograms in 0.3 mL single dose syringe auto-injector | Injection | Adrenaline Jr Viatris |
Adrenaline (epinephrine) | GRP-22361 | I.M. injection 300 micrograms in 0.3 mL single dose syringe auto-injector | Injection | Adrenaline Viatris |
Aflibercept | GRP-24277 | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe | Injection | Eylea |
Aflibercept | GRP-24277 | Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL) | Injection | Eylea |
Alendronic acid | GRP-19660 | Tablet 70 mg (as alendronate sodium) | Oral | Alendronate Sandoz |
Allopurinol | GRP-15579 | Tablet 100 mg | Oral | Allopurinol APOTEX |
Allopurinol | GRP-19808 | Tablet 300 mg | Oral | Allopurinol APOTEX |
Alprazolam | GRP-21744 | Tablet 1 mg | Oral | Alprax 1 |
Alprazolam | GRP-21739 | Tablet 500 micrograms | Oral | Alprax 0.5 |
Amantadine | GRP-28296 | Capsule containing amantadine hydrochloride 100 mg | Oral | AMANTAMED |
Ambrisentan | GRP-24438 | Tablet 10 mg | Oral | Ambrisentan Viatris |
Ambrisentan | GRP-24436 | Tablet 5 mg | Oral | Ambrisentan Viatris |
Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids and medium chain triglycerides | GRP-27823 | Oral powder 400 g (Alfamino) | Oral | Alfamino |
Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids and medium chain triglycerides | GRP-27823 | Oral powder with 2'-fucosyllactose and lacto-N-neotetraose, 400 g (Alfamino) | Oral | Alfamino |
Amiodarone | GRP-19644 | Tablet containing amiodarone hydrochloride 100 mg | Oral | Aratac 100 |
Amiodarone | GRP-19926 | Tablet containing amiodarone hydrochloride 200 mg | Oral | Amdarone |
Amisulpride | GRP-19930 | Tablet 100 mg | Oral | Amisulpride Sandoz Pharma |
Amisulpride | GRP-19672 | Tablet 200 mg | Oral | Amisulpride Sandoz Pharma |
Amisulpride | GRP-19732 | Tablet 400 mg | Oral | Amipride 400 |
Amitriptyline | GRP-19960 | Tablet containing amitriptyline hydrochloride 10 mg | Oral | Amitriptyline Lupin |
Amitriptyline | GRP-19959 | Tablet containing amitriptyline hydrochloride 25 mg | Oral | Amitriptyline Lupin |
Amitriptyline | GRP-19962 | Tablet containing amitriptyline hydrochloride 50 mg | Oral | Amitriptyline Lupin |
Amlodipine | GRP-19809 | Tablet 10 mg (as besilate) | Oral | Amlo 10 |
Amlodipine | GRP-19712 | Tablet 5 mg (as besilate) | Oral | Amlo 5 |
Amlodipine with atorvastatin | GRP-19713 | Tablet 10 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium) | Oral | Cadivast 10/10 |
Amlodipine with atorvastatin | GRP-19666 | Tablet 10 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium) | Oral | Cadivast 10/20 |
Amlodipine with atorvastatin | GRP-19849 | Tablet 10 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium) | Oral | Cadivast 10/40 |
Amlodipine with atorvastatin | GRP-19927 | Tablet 10 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium) | Oral | Cadivast 10/80 |
Amlodipine with atorvastatin | GRP-19788 | Tablet 5 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium) | Oral | Cadivast 5/40 |
Amlodipine with atorvastatin | GRP-19632 | Tablet 5 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium) | Oral | Cadivast 5/80 |
Amlodipine with valsartan | GRP-22201 | Tablet 10 mg (as besilate)-160 mg | Oral | Amlodipine/Valsartan Novartis 10/160 |
Amlodipine with valsartan | GRP-22211 | Tablet 10 mg (as besilate)-320 mg | Oral | Amlodipine/Valsartan Novartis 10/320 |
Amlodipine with valsartan | GRP-22209 | Tablet 5 mg (as besilate)-160 mg | Oral | Amlodipine/Valsartan Novartis 5/160 |
Amlodipine with valsartan | GRP-22208 | Tablet 5 mg (as besilate)-320 mg | Oral | Amlodipine/Valsartan Novartis 5/320 |
Amlodipine with valsartan | GRP-19839 | Tablet 5 mg (as besilate)-80 mg | Oral | Amlodipine/Valsartan Novartis 5/80 |
Amlodipine with valsartan and hydrochlorothiazide | GRP-22203 | Tablet 10 mg (as besilate)-160 mg-12.5 mg | Oral | Amlodipine/Valsartan/HCT Novartis 10/160/12.5 |
Amlodipine with valsartan and hydrochlorothiazide | GRP-22202 | Tablet 10 mg (as besilate)-160 mg-25 mg | Oral | Amlodipine/Valsartan/HCT Novartis 10/160/25 |
Amlodipine with valsartan and hydrochlorothiazide | GRP-22207 | Tablet 10 mg (as besilate)-320 mg-25 mg | Oral | Amlodipine/Valsartan/HCT Novartis 10/320/25 |
Amlodipine with valsartan and hydrochlorothiazide | GRP-19956 | Tablet 5 mg (as besilate)-160 mg-12.5 mg | Oral | Amlodipine/Valsartan/HCT Novartis 5/160/12.5 |
Amlodipine with valsartan and hydrochlorothiazide | GRP-22204 | Tablet 5 mg (as besilate)-160 mg-25 mg | Oral | Amlodipine/Valsartan/HCT Novartis 5/160/25 Exforge HCT 5/160/25 |
Amoxicillin | GRP-20029 | Capsule 250 mg (as trihydrate) | Oral | Alphamox 250 |
Amoxicillin | GRP-20241 | Capsule 500 mg (as trihydrate) | Oral | Alphamox 500 |
Amoxicillin | GRP-20061 | Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL | Oral | Amoxil |
Amoxicillin | GRP-26767 | Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL | Oral | Amoxil Forte |
Amoxicillin | GRP-19635 | Tablet 1 g (as trihydrate) | Oral | Amoxycillin Sandoz |
Amoxicillin with clavulanic acid | GRP-28006 | Powder for oral suspension containing 400 mg amoxicillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL | Oral | Augmentin Duo 400 |
Amoxicillin with clavulanic acid | GRP-20135 | Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) | Oral | AlphaClav Duo |
Amoxicillin with clavulanic acid | GRP-26768 | Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) | Oral | AlphaClav Duo Forte |
Anastrozole | GRP-19931 | Tablet 1 mg | Oral | Anastrozole GH |
Apomorphine | GRP-22998 | Solution for subcutaneous injection containing apomorphine hydrochloride 30 mg in 3 mL pre-filled pen | Injection | Apomine Intermittent |
Aprepitant | GRP-23389 | Capsule 165 mg | Oral | Aprepitant APOTEX |
Aripiprazole | GRP-20893 | Tablet 10 mg | Oral | Abilify |
Aripiprazole | GRP-20895 | Tablet 15 mg | Oral | Abilify |
Aripiprazole | GRP-20910 | Tablet 20 mg | Oral | Abilify |
Aripiprazole | GRP-20908 | Tablet 30 mg | Oral | Abilify |
Atenolol | GRP-19895 | Tablet 50 mg | Oral | APO-Atenolol |
Atomoxetine | GRP-20897 | Capsule 10 mg (as hydrochloride) | Oral | APO-Atomoxetine |
Atomoxetine | GRP-20902 | Capsule 100 mg (as hydrochloride) | Oral | APO-Atomoxetine |
Atomoxetine | GRP-20905 | Capsule 18 mg (as hydrochloride) | Oral | APO-Atomoxetine |
Atomoxetine | GRP-20889 | Capsule 25 mg (as hydrochloride) | Oral | APO-Atomoxetine |
Atomoxetine | GRP-20900 | Capsule 40 mg (as hydrochloride) | Oral | APO-Atomoxetine |
Atomoxetine | GRP-20903 | Capsule 60 mg (as hydrochloride) | Oral | APO-Atomoxetine |
Atomoxetine | GRP-20901 | Capsule 80 mg (as hydrochloride) | Oral | APO-Atomoxetine |
Atorvastatin | GRP-19978 | Tablet 10 mg (as calcium) | Oral | APO-Atorvastatin |
Atorvastatin | GRP-19975 | Tablet 20 mg (as calcium) | Oral | APO-Atorvastatin |
Atorvastatin | GRP-20048 | Tablet 40 mg (as calcium) | Oral | APO-Atorvastatin |
Atorvastatin | GRP-20251 | Tablet 80 mg (as calcium) | Oral | APO-Atorvastatin |
Atovaquone with proguanil | GRP-27571 | Tablet containing atovaquone 250 mg with proguanil hydrochloride 100 mg | Oral | AtovaquoPro Lupin 250/100 |
Azacitidine | GRP-20703 | Powder for injection 100 mg | Injection | Azacitidine Accord |
Azathioprine | GRP-19937 | Tablet 25 mg | Oral | APO-Azathioprine |
Azathioprine | GRP-19674 | Tablet 50 mg | Oral | APO-Azathioprine |
Azithromycin | GRP-19990 | Tablet 500 mg (as dihydrate) | Oral | APO-Azithromycin |
Baclofen | GRP-21530 | Intrathecal injection 10 mg in 5 mL | Injection | Bacthecal |
Baclofen | GRP-19941 | Tablet 10 mg | Oral | APO-Baclofen |
Baclofen | GRP-19905 | Tablet 25 mg | Oral | APO-Baclofen |
Benzathine benzylpenicillin | GRP-28213 | Injection containing 1,200,000 units benzathine benzylpenicillin tetrahydrate in 2.3 mL single use pre-filled syringe | Injection | Bicillin L-A |
Benzathine benzylpenicillin | GRP-28213 | Powder for injection 1,200,000 units with diluent 5 mL (S19A) | Injection | Extencilline Benzathine Benzylpenicillin (France) |
Betamethasone | GRP-19782 | Cream 200 micrograms (as valerate) per g, 100 g | Application | Antroquoril |
Betamethasone | GRP-19946 | Cream 200 micrograms (as valerate) per g, 100 g | Application | Betnovate 1/5 |
Betamethasone | GRP-19864 | Cream 500 micrograms (as dipropionate) per g, 15 g | Application | Diprosone |
Betamethasone | GRP-19733 | Cream 500 micrograms (as valerate) per g, 15 g | Application | Betnovate 1/2 |
Betamethasone | GRP-19903 | Ointment 500 micrograms (as dipropionate) per g, 15 g | Application | Diprosone |
Betaxolol | GRP-20098 | Eye drops, solution, 5 mg (as hydrochloride) per mL, 5 mL | Application to the eye | Betoptic |
Bicalutamide | GRP-19638 | Tablet 50 mg | Oral | APO-Bicalutamide |
Bimatoprost | GRP-21740 | Eye drops 300 micrograms per mL, 3 mL | Application to the eye | Bimatoprost Sandoz |
Bisacodyl | GRP-20157 | Suppositories 10 mg, 10 | RECTAL | Dulcolax |
Bisoprolol | GRP-19813 | Tablet containing bisoprolol fumarate 10 mg | Oral | APO-Bisoprolol |
Bisoprolol | GRP-19779 | Tablet containing bisoprolol fumarate 2.5 mg | Oral | APO-Bisoprolol |
Bisoprolol | GRP-19812 | Tablet containing bisoprolol fumarate 5 mg | Oral | APO-Bisoprolol |
Bivalirudin | GRP-21165 | Powder for I.V. injection 250 mg (as trifluoroacetate) | Injection | BIVALIRUDIN ARX |
Bosentan | GRP-21629 | Tablet 125 mg (as monohydrate) | Oral | Bosentan APO |
Bosentan | GRP-21635 | Tablet 62.5 mg (as monohydrate) | Oral | Bosentan APO |
Brimonidine | GRP-20314 | Eye drops containing brimonidine tartrate 2 mg per mL, 5 mL | Application to the eye | Alphagan |
Brinzolamide | GRP-20064 | Eye drops 10 mg per mL, 5 mL | Application to the eye | Azopt |
Budesonide with formoterol | GRP-22141 | Powder for oral inhalation in breath actuated device containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses | Inhalation by mouth | BiResp Spiromax |
Budesonide with formoterol | GRP-22143 | Powder for oral inhalation in breath actuated device containing budesonide 400 micrograms with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses | Inhalation by mouth | BiResp Spiromax |
Budesonide with formoterol | GRP-27568 | Pressurised inhalation containing budesonide 100 micrograms with formoterol fumarate dihydrate 3 micrograms per dose, 120 doses | Inhalation by mouth | Rilast RAPIHALER 100/3 |
Budesonide with formoterol | GRP-27583 | Pressurised inhalation containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses | Inhalation by mouth | Rilast RAPIHALER 200/6 |
Buprenorphine | GRP-22373 | Transdermal patch 10 mg | Transdermal | B-Patch |
Buprenorphine | GRP-22459 | Transdermal patch 15 mg | Transdermal | B-Patch |
Buprenorphine | GRP-22372 | Transdermal patch 20 mg | Transdermal | B-Patch |
Buprenorphine | GRP-24286 | Transdermal patch 25 mg | Transdermal | Bupredermal |
Buprenorphine | GRP-24274 | Transdermal patch 30 mg | Transdermal | Bupredermal |
Buprenorphine | GRP-24293 | Transdermal patch 40 mg | Transdermal | Bupredermal |
Buprenorphine | GRP-22384 | Transdermal patch 5 mg | Transdermal | B-Patch |
Calcipotriol with betamethasone | GRP-21266 | Ointment containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 30 g | Application | Calcipotriol/Betamethasone Sandoz 50/500 |
Calcitriol | GRP-19708 | Capsule 0.25 microgram | Oral | APO-Calcitriol |
Candesartan | GRP-19568 | Tablet containing candesartan cilexetil 16 mg | Oral | Adesan |
Candesartan | GRP-19564 | Tablet containing candesartan cilexetil 32 mg | Oral | Adesan |
Candesartan | GRP-19566 | Tablet containing candesartan cilexetil 4 mg | Oral | Adesan |
Candesartan | GRP-19554 | Tablet containing candesartan cilexetil 8 mg | Oral | Adesan |
Candesartan with hydrochlorothiazide | GRP-19567 | Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg | Oral | Adesan HCT 16/12.5 |
Candesartan with hydrochlorothiazide | GRP-19563 | Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg | Oral | Adesan HCT 32/12.5 |
Candesartan with hydrochlorothiazide | GRP-19559 | Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg | Oral | Adesan HCT 32/25 |
Capecitabine | GRP-19591 | Tablet 500 mg | Oral | Capecitabine Alphapharm |
Carbamazepine | GRP-19583 | Tablet 100 mg | Oral | Carbamazepine Sandoz |
Carbamazepine | GRP-14653 | Tablet 200 mg | Oral | Carbamazepine Sandoz |
Carbimazole | GRP-24069 | Tablet 5 mg | Oral | Neo-Mercazole |
Carbomer | GRP-20037 | Eye gel 2 mg per g, 10 g | Application to the eye | Optifresh eye gel |
Carvedilol | GRP-19636 | Tablet 12.5 mg | Oral | APO-Carvedilol |
Carvedilol | GRP-19677 | Tablet 25 mg | Oral | APO-Carvedilol |
Carvedilol | GRP-19703 | Tablet 3.125 mg | Oral | APO-Carvedilol |
Carvedilol | GRP-19799 | Tablet 6.25 mg | Oral | APO-Carvedilol |
Cefaclor | GRP-20181 | Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL | Oral | Aclor 250 |
Cefaclor | GRP-19974 | Tablet (sustained release) 375 mg (as monohydrate) | Oral | Ceclor CD |
Cefaclor | GRP-20159 | Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL | Oral | Aclor 125 |
Cefalexin | GRP-20033 | Capsule 250 mg (as monohydrate) | Oral | APO-Cephalexin |
Cefalexin | GRP-20298 | Capsule 500 mg (as monohydrate) | Oral | APO-Cephalexin |
Cefalexin | GRP-20166 | Granules for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL | Oral | Cefalexin Sandoz |
Cefalexin | GRP-27406 | Granules for oral suspension 250 mg (as monohydrate) per 5 mL, 100 mL | Oral | Cefalexin Sandoz |
Cefazolin | GRP-24221 | Powder for injection 2 g (as sodium) | Injection | Cephazolin Alphapharm |
Cefepime | GRP-19794 | Powder for injection 1 g (as hydrochloride) | Injection | Cefepime Kabi |
Cefepime | GRP-19925 | Powder for injection 2 g (as hydrochloride) | Injection | Cefepime Kabi |
Ceftriaxone | GRP-15946 | Powder for injection 1 g (as sodium) | Injection | Ceftriaxone Alphapharm |
Ceftriaxone | GRP-21683 | Powder for injection 2 g (as sodium) | Injection | Ceftriaxone Alphapharm |
Cefuroxime | GRP-22638 | Tablet 250 mg (as axetil) | Oral | Pharmacor Cefuroxime |
Celecoxib | GRP-19618 | Capsule 100 mg | Oral | APX-Celecoxib |
Celecoxib | GRP-19623 | Capsule 200 mg | Oral | APX-Celecoxib |
Ciclosporin | GRP-20026 | Capsule 100 mg | Oral | APO-Ciclosporin |
Ciclosporin | GRP-20032 | Capsule 25 mg | Oral | APO-Ciclosporin |
Ciclosporin | GRP-20143 | Capsule 50 mg | Oral | APO-Ciclosporin |
Cinacalcet | GRP-24882 | Tablet 30 mg (as hydrochloride) | Oral | Cinacalcet Viatris |
Cinacalcet | GRP-24888 | Tablet 60 mg (as hydrochloride) | Oral | Cinacalcet Viatris |
Cinacalcet | GRP-24892 | Tablet 90 mg (as hydrochloride) | Oral | Cinacalcet Mylan |
Ciprofloxacin | GRP-19988 | Eye drops 3 mg (as hydrochloride) per mL, 5 mL | Application to the eye | CiloQuin |
Ciprofloxacin | GRP-19910 | Tablet 250 mg (as hydrochloride) | Oral | APO-Ciprofloxacin |
Ciprofloxacin | GRP-19859 | Tablet 500 mg (as hydrochloride) | Oral | APO-Ciprofloxacin |
Ciprofloxacin | GRP-19723 | Tablet 750 mg (as hydrochloride) | Oral | APO-Ciprofloxacin |
Citalopram | GRP-19953 | Tablet 10 mg (as hydrobromide) | Oral | Celapram |
Citalopram | GRP-19940 | Tablet 20 mg (as hydrobromide) | Oral | APO-Citalopram |
Citalopram | GRP-19656 | Tablet 40 mg (as hydrobromide) | Oral | APO-Citalopram |
Clarithromycin | GRP-19649 | Tablet 250 mg | Oral | Clarithro 250 |
Clindamycin | GRP-19995 | Capsule 150 mg (as hydrochloride) | Oral | APO-Clindamycin |
Clomipramine | GRP-19890 | Tablet containing clomipramine hydrochloride 25 mg | Oral | Anafranil 25 |
Clonazepam | GRP-22717 | Tablet 500 micrograms | Oral | Paxam 0.5 |
Clonidine | GRP-21381 | Tablet containing clonidine hydrochloride 100 micrograms | Oral | APO-Clonidine |
Clopidogrel | GRP-15826 | Tablet 75 mg (as besilate) | Oral | BTC Clopidogrel |
Clopidogrel | GRP-15826 | Tablet 75 mg (as hydrogen sulfate) | Oral | Blooms Clopidogrel |
Clopidogrel with aspirin | GRP-19773 | Tablet 75 mg (as hydrogen sulfate)-100 mg | Oral | APX-Clopidogrel/Aspirin 75/100 |
Codeine with paracetamol | GRP-20169 | Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg | Oral | APO- Paracetamol/Codeine 500/30 |
Colchicine | GRP-19820 | Tablet 500 micrograms | Oral | Colcine |
Cyproterone | GRP-19842 | Tablet containing cyproterone acetate 100 mg | Oral | Androcur-100 |
Cyproterone | GRP-19722 | Tablet containing cyproterone acetate 50 mg | Oral | Androcur |
Dabigatran etexilate | GRP-28121 | Capsule 110 mg (as mesilate) | Oral | ARX-Dabigatran |
Dabigatran etexilate | GRP-28118 | Capsule 150 mg (as mesilate) | Oral | ARX-Dabigatran |
Dabigatran etexilate | GRP-28127 | Capsule 75 mg (as mesilate) | Oral | ARX-Dabigatran |
Darunavir | GRP-24212 | Tablet 600 mg | Oral | Darunavir Juno |
Darunavir | GRP-24212 | Tablet 600 mg (as ethanolate) | Oral | Prezista |
Darunavir | GRP-25566 | Tablet 800 mg | Oral | Darunavir Juno |
Darunavir | GRP-25566 | Tablet 800 mg (as ethanolate) | Oral | Prezista |
Dasatinib | GRP-25880 | Tablet 100 mg | Oral | Dasatinib ARX |
Dasatinib | GRP-25849 | Tablet 20 mg | Oral | Dasatinib ARX |
Dasatinib | GRP-25853 | Tablet 50 mg | Oral | Dasatinib ARX |
Dasatinib | GRP-25848 | Tablet 70 mg | Oral | Dasatinib ARX |
Deferasirox | GRP-25391 | Tablet 180 mg | Oral | Deferasirox ARX |
Deferasirox | GRP-25395 | Tablet 360 mg | Oral | Deferasirox ARX |
Deferasirox | GRP-25385 | Tablet 90 mg | Oral | Deferasirox ARX |
Deferasirox | GRP-28209 | Tablet, dispersible, 125 mg | Oral | Deferasirox Juno |
Deferasirox | GRP-28210 | Tablet, dispersible, 250 mg | Oral | Deferasirox Juno |
Deferasirox | GRP-28219 | Tablet, dispersible, 500 mg | Oral | Deferasirox Juno |
Desmopressin | GRP-24629 | Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 50 actuations, 5 mL, USP (Apotex) | NASAL | Desmopressin Nasal Spray USP (Apotex) |
Desmopressin | GRP-24629 | Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 60 actuations, 6 mL | NASAL | Minirin Nasal Spray |
Desvenlafaxine | GRP-16219 | Tablet (extended release) 100 mg (as succinate) | Oral | Pristiq |
Desvenlafaxine | GRP-16219 | Tablet (modified release) 100 mg | Oral | BTC Desvenlafaxine |
Desvenlafaxine | GRP-16219 | Tablet (modified release) 100 mg (as benzoate) | Oral | APO-Desvenlafaxine MR |
Desvenlafaxine | GRP-16220 | Tablet (extended release) 50 mg (as succinate) | Oral | Pristiq |
Desvenlafaxine | GRP-16220 | Tablet (modified release) 50 mg | Oral | BTC Desvenlafaxine |
Desvenlafaxine | GRP-16220 | Tablet (modified release) 50 mg (as benzoate) | Oral | APO-Desvenlafaxine MR |
Dexamethasone with framycetin and gramicidin | GRP-19777 | Ear drops containing dexamethasone 500 micrograms (as sodium metasulfobenzoate), framycetin sulfate 5 mg and gramicidin 50 micrograms per mL, 8 mL | Application to the ear | Otodex |
Diazepam | GRP-20081 | Tablet 2 mg | Oral | Antenex 2 |
Diazepam | GRP-20001 | Tablet 5 mg | Oral | Antenex 5 |
Diclofenac | GRP-20112 | Tablet (enteric coated) containing diclofenac sodium 25 mg | Oral | APO-Diclofenac |
Diclofenac | GRP-20116 | Tablet (enteric coated) containing diclofenac sodium 50 mg | Oral | APO-Diclofenac |
Dicloxacillin | GRP-22402 | Capsule 250 mg (as sodium) | Oral | Dicloxacillin Mylan 250 |
Dicloxacillin | GRP-20360 | Capsule 500 mg (as sodium) | Oral | Dicloxacillin Mylan 500 |
Digoxin | GRP-19717 | Tablet 250 micrograms | Oral | Lanoxin |
Digoxin | GRP-19774 | Tablet 62.5 micrograms | Oral | Lanoxin-PG |
Diltiazem | GRP-19652 | Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg | Oral | Cardizem CD |
Diltiazem | GRP-19894 | Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg | Oral | Cardizem CD |
Diltiazem | GRP-19934 | Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg | Oral | Cardizem CD |
Diltiazem | GRP-19869 | Tablet containing diltiazem hydrochloride 60 mg | Oral | Cardizem |
Dimethyl fumarate | GRP-26010 | Capsule (modified release) 120 mg | Oral | APO-DIMETHYL FUMARATE |
Dimethyl fumarate | GRP-26012 | Capsule (modified release) 240 mg | Oral | APO-DIMETHYL FUMARATE |
Diphenoxylate with atropine | GRP-19655 | Tablet containing diphenoxylate hydrochloride 2.5 mg with atropine sulfate monohydrate 25 micrograms | Oral | Lofenoxal |
Disopyramide | GRP-27397 | Capsule 100 mg | Oral | Rythmodan |
Disopyramide | GRP-27397 | Capsule 100 mg (s19A) | Oral | Rythmodan (Canada) |
Domperidone | GRP-26945 | Tablet 10 mg | Oral | APO-DOMPERIDONE |
Donepezil | GRP-20245 | Tablet containing donepezil hydrochloride 10 mg | Oral | APO-Donepezil |
Donepezil | GRP-20096 | Tablet containing donepezil hydrochloride 5 mg | Oral | APO-Donepezil |
Dorzolamide | GRP-19989 | Eye drops 20 mg (as hydrochloride) per mL, 5 mL | Application to the eye | Trusamide |
Dorzolamide with timolol | GRP-19979 | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Cosdor |
Dosulepin | GRP-22377 | Capsule containing dosulepin hydrochloride 25 mg | Oral | Dosulepin Viatris |
Dosulepin | GRP-22392 | Tablet containing dosulepin hydrochloride 75 mg | Oral | Dosulepin Viatris 75 |
Doxorubicin - pegylated liposomal | GRP-19578 | Suspension for I.V. infusion containing pegylated liposomal doxorubicin hydrochloride 20 mg in 10 mL | Injection | Caelyx |
Doxycycline | GRP-14639 | Capsule 100 mg (as hyclate) (containing enteric coated pellets) | Oral | Doryx |
Doxycycline | GRP-15635 | Capsule 50 mg (as hyclate) (containing enteric coated pellets) | Oral | Doryx |
Doxycycline | GRP-14639 | Tablet 100 mg (as hyclate) | Oral | APX-Doxycycline |
Doxycycline | GRP-14639 | Tablet 100 mg (as monohydrate) | Oral | Doxycycline Sandoz |
Doxycycline | GRP-15635 | Tablet 50 mg (as hyclate) | Oral | APX-Doxycycline |
Doxycycline | GRP-15635 | Tablet 50 mg (as monohydrate) | Oral | Doxycycline Sandoz |
Duloxetine | GRP-19918 | Capsule 30 mg (as hydrochloride) | Oral | APO-Duloxetine |
Duloxetine | GRP-19957 | Capsule 60 mg (as hydrochloride) | Oral | APO-Duloxetine |
Dutasteride | GRP-21860 | Capsule 500 micrograms | Oral | APO-Dutasteride |
Dutasteride with tamsulosin | GRP-24027 | Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms | Oral | Doubluts |
Enalapril | GRP-19843 | Tablet containing enalapril maleate 10 mg | Oral | Acetec |
Enalapril | GRP-19633 | Tablet containing enalapril maleate 20 mg | Oral | Acetec |
Enalapril | GRP-19752 | Tablet containing enalapril maleate 5 mg | Oral | Acetec |
Enalapril with hydrochlorothiazide | GRP-19645 | Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg | Oral | Enalapril/HCT Sandoz |
Enoxaparin | GRP-22357 | Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection | Clexane Safety-Lock |
Enoxaparin | GRP-28012 | Injection containing enoxaparin sodium 120 mg (12,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection | Clexane Forte Safety-Lock |
Enoxaparin | GRP-28013 | Injection containing enoxaparin sodium 150 mg (15,000 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection | Clexane Forte Safety-Lock |
Enoxaparin | GRP-22387 | Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe | Injection | Clexane Safety-Lock |
Enoxaparin | GRP-22367 | Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe | Injection | Clexane Safety-Lock |
Enoxaparin | GRP-22371 | Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe | Injection | Clexane Safety-Lock |
Enoxaparin | GRP-22378 | Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection | Clexane Safety-Lock |
Entecavir | GRP-21166 | Tablet 0.5 mg (as monohydrate) | Oral | ENTAC |
Entecavir | GRP-21170 | Tablet 1 mg (as monohydrate) | Oral | ENTECAVIR APO |
Eplerenone | GRP-20711 | Tablet 25 mg | Oral | APO-Eplerenone |
Eplerenone | GRP-20704 | Tablet 50 mg | Oral | APO-Eplerenone |
Epoprostenol | GRP-28614 | Powder for I.V. infusion 1.5 mg (as sodium) | Injection | Veletri |
Epoprostenol | GRP-28614 | Powder for I.V. infusion 1.5 mg (as sodium) with 2 vials diluent 50 mL | Injection | Flolan |
Epoprostenol | GRP-28616 | Powder for I.V. infusion 500 micrograms (as sodium) | Injection | Veletri |
Epoprostenol | GRP-28616 | Powder for I.V. infusion 500 micrograms (as sodium) with 2 vials diluent 50 mL | Injection | Flolan |
Erlotinib | GRP-24881 | Tablet 100 mg (as hydrochloride) | Oral | Erlotinib APOTEX |
Erlotinib | GRP-24897 | Tablet 150 mg (as hydrochloride) | Oral | Erlotinib APOTEX |
Erlotinib | GRP-24895 | Tablet 25 mg (as hydrochloride) | Oral | Erlotinib APOTEX |
Escitalopram | GRP-19817 | Tablet 10 mg (as oxalate) | Oral | APO-Escitalopram |
Escitalopram | GRP-19665 | Tablet 20 mg (as oxalate) | Oral | APO-Escitalopram |
Esomeprazole | GRP-17188 | Capsule (enteric) 20 mg (as magnesium) | Oral | Noxicid Caps |
Esomeprazole | GRP-17188 | Tablet (enteric coated) 20 mg (as magnesium trihydrate) | Oral | APO-Esomeprazole |
Esomeprazole | GRP-17061 | Capsule (enteric) 40 mg (as magnesium) | Oral | Noxicid Caps |
Esomeprazole | GRP-17061 | Tablet (enteric coated) 40 mg (as magnesium trihydrate) | Oral | APO-Esomeprazole |
Esomeprazole and clarithromycin and amoxicillin | GRP-20639 | Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate) | Oral | Nexium Hp7 |
Esomeprazole and clarithromycin and amoxicillin | GRP-20639 | Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate) | Oral | ESOMEPRAZOLE SANDOZ Hp7 |
Estradiol | GRP-27217 | Pessary (modified release) 10 micrograms (as hemihydrate) | VAGINAL | Estro-Pess |
Estradiol | GRP-28649 | Transdermal patches 585 micrograms, 8 | Transdermal | Estradiol Transdermal System (Sandoz, USA) |
Estradiol | GRP-28651 | Transdermal patches 1.17 mg, 8 | Transdermal | Estradiol Transdermal System (Sandoz, USA) |
Estradiol | GRP-28652 | Transdermal patches 1.56 mg, 8 | Transdermal | Estradiol Transdermal System (Sandoz, USA) |
Etanercept | GRP-26053 | Injection 50 mg in 1 mL single use auto-injector, 4 | Injection | Brenzys |
Etanercept | GRP-26053 | Injections 50 mg in 1 mL single use pre-filled syringes, 4 | Injection | Brenzys |
Ethosuximide | GRP-23067 | Capsule 250 mg | Oral | Zarontin |
Ethosuximide | GRP-23067 | Capsule 250 mg (s19A) | Oral | Ethosuximide Essential Generics (UK) |
Everolimus | GRP-25324 | Tablet 0.25 mg | Oral | Certican |
Everolimus | GRP-25326 | Tablet 0.5 mg | Oral | Certican |
Everolimus | GRP-25328 | Tablet 0.75 mg | Oral | Certican |
Everolimus | GRP-25323 | Tablet 1 mg | Oral | Certican |
Exemestane | GRP-20304 | Tablet 25 mg | Oral | APO-Exemestane |
Ezetimibe | GRP-22396 | Tablet 10 mg | Oral | APO-Ezetimibe |
Ezetimibe and rosuvastatin | GRP-22388 | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Oral | Ezalo Composite Pack 10mg+10mg |
Ezetimibe and rosuvastatin | GRP-22395 | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Oral | Ezalo Composite Pack 10mg+20mg |
Ezetimibe and rosuvastatin | GRP-22369 | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Oral | Ezalo Composite Pack 10mg+40mg |
Ezetimibe and rosuvastatin | GRP-22399 | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | Oral | Ezalo Composite Pack 10mg+5mg |
Ezetimibe with atorvastatin | GRP-23708 | Tablet 10 mg-10 mg | Oral | Atozet |
Ezetimibe with atorvastatin | GRP-23706 | Tablet 10 mg-20 mg | Oral | Atozet |
Ezetimibe with atorvastatin | GRP-23702 | Tablet 10 mg-40 mg | Oral | Atozet |
Ezetimibe with atorvastatin | GRP-23705 | Tablet 10 mg-80 mg | Oral | Atozet |
Ezetimibe with simvastatin | GRP-22381 | Tablet 10 mg-10 mg | Oral | APO-Ezetimibe/Simvastatin 10/10 |
Ezetimibe with simvastatin | GRP-22383 | Tablet 10 mg-20 mg | Oral | APO-Ezetimibe/Simvastatin 10/20 |
Ezetimibe with simvastatin | GRP-22376 | Tablet 10 mg-40 mg | Oral | APO-Ezetimibe/Simvastatin 10/40 |
Ezetimibe with simvastatin | GRP-22393 | Tablet 10 mg-80 mg | Oral | APO-Ezetimibe/Simvastatin 10/80 |
Famciclovir | GRP-19771 | Tablet 125 mg | Oral | APO-Famciclovir |
Famciclovir | GRP-19828 | Tablet 250 mg | Oral | APO-Famciclovir |
Famciclovir | GRP-19913 | Tablet 500 mg | Oral | APO-Famciclovir |
Felodipine | GRP-19647 | Tablet 10 mg (extended release) | Oral | Felodil XR 10 |
Felodipine | GRP-19691 | Tablet 2.5 mg (extended release) | Oral | Felodur ER 2.5 mg |
Felodipine | GRP-19853 | Tablet 5 mg (extended release) | Oral | Felodil XR 5 |
Fenofibrate | GRP-20712 | Tablet 145 mg | Oral | APO-Fenofibrate |
Fenofibrate | GRP-20717 | Tablet 48 mg | Oral | APO-Fenofibrate |
Fentanyl | GRP-15898 | Transdermal patch 1.28 mg | Transdermal | Denpax |
Fentanyl | GRP-15747 | Transdermal patch 10.20 mg | Transdermal | Denpax |
Fentanyl | GRP-15510 | Transdermal patch 12.375 mg | Transdermal | Fenpatch 75 |
Fentanyl | GRP-15510 | Transdermal patch 12.6 mg | Transdermal | APO-Fentanyl |
Fentanyl | GRP-15747 | Transdermal patch 16.5 mg | Transdermal | Fenpatch 100 |
Fentanyl | GRP-15747 | Transdermal patch 16.8 mg | Transdermal | APO-Fentanyl |
Fentanyl | GRP-15898 | Transdermal patch 2.063 mg | Transdermal | Fenpatch 12 |
Fentanyl | GRP-15898 | Transdermal patch 2.1 mg | Transdermal | APO-Fentanyl |
Fentanyl | GRP-15577 | Transdermal patch 2.55 mg | Transdermal | Denpax |
Fentanyl | GRP-15577 | Transdermal patch 4.125 mg | Transdermal | Fenpatch 25 |
Fentanyl | GRP-15577 | Transdermal patch 4.2 mg | Transdermal | APO-Fentanyl |
Fentanyl | GRP-15659 | Transdermal patch 5.10 mg | Transdermal | Denpax |
Fentanyl | GRP-15510 | Transdermal patch 7.65 mg | Transdermal | Denpax |
Fentanyl | GRP-15659 | Transdermal patch 8.25 mg | Transdermal | Fenpatch 50 |
Fentanyl | GRP-15659 | Transdermal patch 8.4 mg | Transdermal | APO-Fentanyl |
Filgrastim | GRP-23379 | Injection 300 micrograms in 0.5 mL single-use pre-filled syringe | Injection | Nivestim |
Filgrastim | GRP-23385 | Injection 480 micrograms in 0.5 mL single-use pre-filled syringe | Injection | Nivestim |
Fingolimod | GRP-26766 | Capsule 500 micrograms (as hydrochloride) | Oral | AKM Fingolimod |
Flecainide | GRP-19776 | Tablet containing flecainide acetate 100 mg | Oral | APO-Flecainide |
Flecainide | GRP-21022 | Tablet containing flecainide acetate 50 mg | Oral | APO-Flecainide |
Flucloxacillin | GRP-23238 | Capsule 250 mg (as sodium monohydrate) | Oral | Flopen |
Flucloxacillin | GRP-23239 | Capsule 500 mg (as sodium monohydrate) | Oral | Flopen |
Fluconazole | GRP-19878 | Capsule 100 mg | Oral | Diflucan |
Fluconazole | GRP-19858 | Capsule 200 mg | Oral | Diflucan |
Fluconazole | GRP-19877 | Capsule 50 mg | Oral | Diflucan |
Fludrocortisone | GRP-25994 | Tablet containing fludrocortisone acetate 100 micrograms | Oral | Florinef |
Fluoxetine | GRP-24550 | Capsule 20 mg (as hydrochloride) | Oral | APO-Fluoxetine |
Fluticasone propionate | GRP-24883 | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms per dose, 60 doses | Inhalation by mouth | Axotide Junior Accuhaler |
Fluticasone propionate | GRP-24884 | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms per dose, 60 doses | Inhalation by mouth | Axotide Accuhaler |
Fluticasone propionate | GRP-21526 | Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Axotide |
Fluticasone propionate | GRP-21532 | Pressurised inhalation containing fluticasone propionate 250 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Axotide |
Fluticasone propionate | GRP-24885 | Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Axotide Junior |
Fluticasone propionate with salmeterol | GRP-24889 | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | PAVTIDE ACCUHALER 100/50 |
Fluticasone propionate with salmeterol | GRP-24904 | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Fluticasone Salmeterol Ciphaler 250/50 |
Fluticasone propionate with salmeterol | GRP-24913 | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Fluticasone Salmeterol Ciphaler 500/50 |
Fluticasone propionate with salmeterol | GRP-21527 | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Evocair MDI |
Fluticasone propionate with salmeterol | GRP-21522 | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Evocair MDI |
Fluticasone propionate with salmeterol | GRP-24890 | Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | PAVTIDE MDI 50/25 |
Fluvoxamine | GRP-19862 | Tablet containing fluvoxamine maleate 100 mg | Oral | APO-Fluvoxamine |
Fluvoxamine | GRP-19729 | Tablet containing fluvoxamine maleate 50 mg | Oral | APO-Fluvoxamine |
Folic acid | GRP-20404 | Tablet 500 micrograms | Oral | Foltabs 500 |
Follitropin alfa | GRP-25866 | Injection 300 I.U. in 0.5 mL multi-dose cartridge | Injection | Gonal-f Pen |
Follitropin alfa | GRP-25867 | Injection 450 I.U. in 0.75 mL multi-dose cartridge | Injection | Gonal-f Pen |
Follitropin alfa | GRP-25879 | Injection 900 I.U. in 1.5 mL multi-dose cartridge | Injection | Gonal-f Pen |
Follitropin beta | GRP-27207 | Solution for injection 300 I.U. in 0.36 mL multi-dose cartridge | Injection | Puregon 300 IU/0.36 mL |
Follitropin beta | GRP-27212 | Solution for injection 600 I.U. in 0.72 mL multi-dose cartridge | Injection | Puregon 600 IU/0.72 mL |
Follitropin beta | GRP-27211 | Solution for injection 900 I.U. in 1.08 mL multi-dose cartridge | Injection | Puregon 900 IU/1.08 mL |
Fosaprepitant | GRP-27398 | Powder for I.V. infusion 150 mg | Injection | Emend IV |
Fosinopril | GRP-19785 | Tablet containing fosinopril sodium 10 mg | Oral | APO-Fosinopril |
Fosinopril | GRP-19769 | Tablet containing fosinopril sodium 20 mg | Oral | APO-Fosinopril |
Fremanezumab | GRP-26651 | Solution for injection 225 mg in 1.5 mL single dose pre-filled pen | Injection | Ajovy |
Fremanezumab | GRP-26651 | Solution for injection 225 mg in 1.5 mL single dose pre-filled syringe | Injection | Ajovy |
Fulvestrant | GRP-25877 | Injection 250 mg in 5 mL pre-filled syringe | Injection | FULVESTRANT ACCORD |
Furosemide | GRP-15441 | Tablet 20 mg | Oral | APO-Frusemide |
Furosemide | GRP-19673 | Tablet 40 mg | Oral | APO-Frusemide |
Gabapentin | GRP-20038 | Capsule 100 mg | Oral | APX-Gabapentin |
Gabapentin | GRP-20136 | Capsule 300 mg | Oral | APX-Gabapentin |
Gabapentin | GRP-20293 | Capsule 400 mg | Oral | APX-Gabapentin |
Gabapentin | GRP-20075 | Tablet 600 mg | Oral | Gabapentin APOTEX |
Gabapentin | GRP-20089 | Tablet 800 mg | Oral | Gabapentin APOTEX |
Galantamine | GRP-20219 | Capsule (prolonged release) 16 mg (as hydrobromide) | Oral | APO-Galantamine MR |
Galantamine | GRP-19984 | Capsule (prolonged release) 24 mg (as hydrobromide) | Oral | APO-Galantamine MR |
Galantamine | GRP-20010 | Capsule (prolonged release) 8 mg (as hydrobromide) | Oral | APO-Galantamine MR |
Ganciclovir | GRP-22142 | Powder for I.V. infusion 500 mg (as sodium) | Injection | Cymevene |
Ganirelix | GRP-24916 | Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe | Injection | GANIRELIX SUN |
Gemfibrozil | GRP-20132 | Tablet 600 mg | Oral | Ausgem |
Glatiramer | GRP-26552 | Injection containing glatiramer acetate 40 mg in 1 mL single dose pre-filled pen | Injection | Copaxone |
Glatiramer | GRP-26552 | Injection containing glatiramer acetate 40 mg in 1 mL single dose pre-filled syringe | Injection | Copaxone |
Gliclazide | GRP-19637 | Tablet 30 mg (modified release) | Oral | APO-Gliclazide MR |
Gliclazide | GRP-19611 | Tablet 60 mg (modified release) | Oral | ARDIX GLICLAZIDE 60mg MR |
Gliclazide | GRP-19933 | Tablet 80 mg | Oral | APO-Gliclazide |
Glimepiride | GRP-19887 | Tablet 1 mg | Oral | Amaryl |
Glimepiride | GRP-19711 | Tablet 2 mg | Oral | ARX-GLIMEPIRIDE |
Glimepiride | GRP-19855 | Tablet 4 mg | Oral | ARX-GLIMEPIRIDE |
Glimepiride | GRP-19770 | Tablet 3 mg | Oral | ARX-GLIMEPIRIDE |
Glipizide | GRP-19686 | Tablet 5 mg | Oral | Melizide |
Granisetron | GRP-20012 | Concentrated injection 3 mg (as hydrochloride) in 3 mL | Injection | Granisetron Kabi |
Hydrocortisone | GRP-20194 | Cream containing hydrocortisone acetate 10 mg per g, 50 g | Application | Cortic-DS 1% |
Hydrocortisone | GRP-20005 | Ointment containing hydrocortisone acetate 10 mg per g, 50 g | Application | Cortic-DS 1% |
Hydrocortisone | GRP-22397 | Tablet 20 mg | Oral | Hydrocortisone Viatris 20 |
Hydrocortisone | GRP-22370 | Tablet 4 mg | Oral | Hydrocortisone Viatris 4 |
Hydromorphone | GRP-23240 | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | Dilaudid-HP |
Hydromorphone | GRP-23244 | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | Dilaudid |
Hydromorphone | GRP-28212 | Oral solution containing hydromorphone hydrochloride 1 mg per mL, 1 mL | Oral | Hikma |
Hydromorphone | GRP-28212 | Oral solution containing hydromorphone hydrochloride 1mg per mL, 1mL (S19A) | Oral | Hydromorphone hydrochloride oral solution, USP (Medsurge) |
Hydroxocobalamin | GRP-17689 | Injection 1 mg (as acetate) in 1 mL | Injection | Cobal-B12 |
Hydroxocobalamin | GRP-17689 | Injection 1 mg (as chloride) in 1 mL | Injection | Hydroxo-B12 |
Hydroxycarbamide | GRP-24269 | Capsule 500 mg | Oral | Hydrea |
Hydroxychloroquine | GRP-19846 | Tablet containing hydroxychloroquine sulfate 200 mg | Oral | APO- Hydroxychloroquine |
Hyoscine | GRP-21862 | Injection containing hyoscine butylbromide 20 mg in 1 mL | Injection | Buscopan |
Hypromellose | GRP-22878 | Eye drops 3 mg per mL, 10 mL | Application to the eye | Genteal |
Hypromellose with carbomer 980 | GRP-20137 | Ocular lubricating gel 3 mg-2 mg per g, 10 g | Application to the eye | Genteal gel |
Hypromellose with dextran | GRP-20049 | Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL | Application to the eye | Poly-Tears |
Ibuprofen | GRP-21741 | Tablet 400 mg | Oral | APO-Ibuprofen 400 |
Icatibant | GRP-24276 | Injection 30 mg (as acetate) in 3 mL single use pre-filled syringe | Injection | Cipla Icatibant |
Imatinib | GRP-21074 | Capsule 100 mg (as mesilate) | Oral | Imatinib-APOTEX |
Imatinib | GRP-21079 | Capsule 400 mg (as mesilate) | Oral | Imatinib GH |
Imatinib | GRP-21074 | Tablet 100 mg (as mesilate) | Oral | Gilmat |
Imatinib | GRP-21079 | Tablet 400 mg (as mesilate) | Oral | Gilmat |
Imipramine | GRP-24222 | Tablet containing imipramine hydrochloride 25 mg | Oral | Tofranil 25 |
Imipramine | GRP-24222 | Tablet containing imipramine hydrochloride 25 mg (s19A) | Oral | Imipramine (Leading) |
Imiquimod | GRP-17065 | Cream 50 mg per g, 2 g, 2 | Application | Aldara Pump |
Imiquimod | GRP-17065 | Cream 50 mg per g, 250 mg single use sachets, 12 | Application | Aldara |
Indapamide | GRP-19607 | Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | Oral | APO-Indapamide SR |
Indapamide | GRP-19781 | Tablet containing indapamide hemihydrate 2.5 mg | Oral | Dapa-Tabs |
Indometacin | GRP-20071 | Capsule 25 mg | Oral | Arthrexin |
Infliximab | GRP-20382 | Powder for I.V. infusion 100 mg | Injection | Inflectra |
Ipratropium | GRP-19908 | Nebuliser solution containing ipratropium bromide 250 micrograms (as monohydrate) in 1 mL single dose units, 30 | Inhalation | Aeron 250 |
Ipratropium | GRP-19679 | Nebuliser solution containing ipratropium bromide 500 micrograms (as monohydrate) in 1 mL single dose units, 30 | Inhalation | Aeron 500 |
Irbesartan | GRP-19659 | Tablet 150 mg | Oral | Abisart 150 |
Irbesartan | GRP-19742 | Tablet 300 mg | Oral | Abisart 300 |
Irbesartan | GRP-19646 | Tablet 75 mg | Oral | Abisart 75 |
Irbesartan with hydrochlorothiazide | GRP-19958 | Tablet 150 mg-12.5 mg | Oral | Abisart HCTZ 150/12.5 |
Irbesartan with hydrochlorothiazide | GRP-19743 | Tablet 300 mg-12.5 mg | Oral | Abisart HCTZ 300/12.5 |
Irbesartan with hydrochlorothiazide | GRP-19699 | Tablet 300 mg-25 mg | Oral | Abisart HCTZ 300/25 |
Isosorbide mononitrate | GRP-19675 | Tablet 120 mg (sustained release) | Oral | Imdur 120 mg |
Isosorbide mononitrate | GRP-19856 | Tablet 60 mg (sustained release) | Oral | APO-Isosorbide Mononitrate |
Isotretinoin | GRP-19867 | Capsule 10 mg | Oral | APO-Isotretinoin |
Isotretinoin | GRP-22820 | Capsule 20 mg | Oral | APO-Isotretinoin |
Isotretinoin | GRP-19603 | Capsule 40 mg | Oral | Dermatane |
Itraconazole | GRP-21159 | Capsule 100 mg | Oral | APO-Itraconazole |
Ivabradine | GRP-22577 | Tablet 5 mg (as hydrochloride) | Oral | APO-Ivabradine |
Ivabradine | GRP-22578 | Tablet 7.5 mg (as hydrochloride) | Oral | APO-Ivabradine |
Ketoprofen | GRP-20014 | Capsule 200 mg (sustained release) | Oral | Orudis SR 200 |
Lacosamide | GRP-26166 | Tablet 100 mg | Oral | Lacoress |
Lacosamide | GRP-26170 | Tablet 150 mg | Oral | Lacoress |
Lacosamide | GRP-26173 | Tablet 200 mg | Oral | Lacoress |
Lacosamide | GRP-26169 | Tablet 50 mg | Oral | Lacoress |
Lamivudine | GRP-19806 | Tablet 100 mg | Oral | Zeffix |
Lamivudine | GRP-19929 | Tablet 150 mg | Oral | 3TC |
Lamivudine | GRP-19748 | Tablet 300 mg | Oral | 3TC |
Lamivudine with zidovudine | GRP-19570 | Tablet 150 mg-300 mg | Oral | Combivir |
Lamotrigine | GRP-19706 | Tablet 100 mg | Oral | APX-Lamotrigine |
Lamotrigine | GRP-19640 | Tablet 200 mg | Oral | APX-Lamotrigine |
Lamotrigine | GRP-19807 | Tablet 25 mg | Oral | APX-Lamotrigine |
Lamotrigine | GRP-19758 | Tablet 50 mg | Oral | APX-Lamotrigine |
Lanreotide | GRP-27567 | Injection 120 mg (as acetate) in single dose pre-filled syringe | Injection | Mytolac |
Lanreotide | GRP-27569 | Injection 60 mg (as acetate) in single dose pre-filled syringe | Injection | Mytolac |
Lanreotide | GRP-27570 | Injection 90 mg (as acetate) in single dose pre-filled syringe | Injection | Mytolac |
Lansoprazole | GRP-14641 | Capsule 30 mg | Oral | APO-Lansoprazole |
Lansoprazole | GRP-19832 | Tablet 15 mg (orally disintegrating) | Oral | APO-Lansoprazole ODT |
Lansoprazole | GRP-14641 | Tablet 30 mg (orally disintegrating) | Oral | APO-Lansoprazole ODT |
Latanoprost | GRP-20084 | Eye drops 50 micrograms per mL, 2.5 mL | Application to the eye | APO-Latanoprost |
Latanoprost with timolol | GRP-20063 | Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye | APO-Latanoprost/Timolol 0.05/5 |
Leflunomide | GRP-19866 | Tablet 10 mg | Oral | APO-LEFLUNOMIDE |
Leflunomide | GRP-19639 | Tablet 20 mg | Oral | APO-LEFLUNOMIDE |
Lercanidipine | GRP-19911 | Tablet containing lercanidipine hydrochloride 10 mg | Oral | ARX-LERCANIDIPINE |
Lercanidipine | GRP-19829 | Tablet containing lercanidipine hydrochloride 20 mg | Oral | ARX-LERCANIDIPINE |
Letrozole | GRP-19884 | Tablet 2.5 mg | Oral | ARX-LETROZOLE |
Levetiracetam | GRP-20362 | Oral solution 100 mg per mL, 300 mL | Oral | APO-Levetiracetam |
Levetiracetam | GRP-28396 | Tablet 1 g | Oral | APO-Levetiracetam |
Levetiracetam | GRP-19648 | Tablet 250 mg | Oral | APO-Levetiracetam |
Levetiracetam | GRP-28461 | Tablet 500 mg | Oral | APO-Levetiracetam |
Levodopa with carbidopa | GRP-19870 | Tablet 100 mg-25 mg (as monohydrate) | Oral | APO-Levodopa/Carbidopa |
Levodopa with carbidopa | GRP-22958 | Tablet 250 mg-25 mg (as monohydrate) | Oral | APO-Levodopa/Carbidopa |
Levodopa with carbidopa and entacapone | GRP-24201 | Tablet 100 mg-25 mg (as monohydrate)-200 mg | Oral | Carlevent |
Levodopa with carbidopa and entacapone | GRP-24193 | Tablet 125 mg-31.25 mg (as monohydrate)-200 mg | Oral | Carlevent |
Levodopa with carbidopa and entacapone | GRP-24197 | Tablet 150 mg-37.5 mg (as monohydrate)-200 mg | Oral | Carlevent |
Levodopa with carbidopa and entacapone | GRP-24203 | Tablet 200 mg-50 mg (as monohydrate)-200 mg | Oral | Carlevent |
Levodopa with carbidopa and entacapone | GRP-24192 | Tablet 50 mg-12.5 mg (as monohydrate)-200 mg | Oral | Carlevent |
Levodopa with carbidopa and entacapone | GRP-24198 | Tablet 75 mg-18.75 mg (as monohydrate)-200 mg | Oral | Carlevent |
Levonorgestrel with ethinylestradiol | GRP-19827 | Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets | Oral | Eleanor 150/30 ED |
Levonorgestrel with ethinylestradiol | GRP-19824 | Pack containing 6 tablets 50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets | Oral | Logynon ED |
Levothyroxine | GRP-26248 | Tablet containing 100 micrograms anhydrous levothyroxine sodium | Oral | APO-Levothyroxine |
Levothyroxine | GRP-27411 | Tablet containing 100 micrograms anhydrous levothyroxine sodium | Oral | Eltroxin |
Levothyroxine | GRP-26246 | Tablet containing 200 micrograms anhydrous levothyroxine sodium | Oral | APO-Levothyroxine |
Levothyroxine | GRP-27400 | Tablet containing 200 micrograms anhydrous levothyroxine sodium | Oral | Eltroxin |
Levothyroxine | GRP-26247 | Tablet containing 50 micrograms anhydrous levothyroxine sodium | Oral | APO-Levothyroxine |
Levothyroxine | GRP-27402 | Tablet containing 50 micrograms anhydrous levothyroxine sodium | Oral | Eltroxin |
Levothyroxine | GRP-26249 | Tablet containing 75 micrograms anhydrous levothyroxine sodium | Oral | APO-Levothyroxine |
Levothyroxine | GRP-27401 | Tablet containing 75 micrograms anhydrous levothyroxine sodium | Oral | Eltroxin |
Lincomycin | GRP-22364 | Injection 600 mg (as hydrochloride monohydrate) in 2 mL | Injection | Lincocin |
Lisinopril | GRP-19764 | Tablet 10 mg | Oral | APO-Lisinopril |
Lisinopril | GRP-19761 | Tablet 20 mg | Oral | APO-Lisinopril |
Lisinopril | GRP-19823 | Tablet 5 mg | Oral | APO-Lisinopril |
Loperamide | GRP-20401 | Capsule containing loperamide hydrochloride 2 mg | Oral | Gastrex |
Lurasidone | GRP-24195 | Tablet containing lurasidone hydrochloride 40 mg | Oral | APO-Lurasidone |
Lurasidone | GRP-24194 | Tablet containing lurasidone hydrochloride 80 mg | Oral | APO-Lurasidone |
Macrogol 3350 | GRP-20122 | Sachets containing powder for oral solution 13.125 g with electrolytes, 30 | Oral | APOHEALTH Macrogol with Electrolytes |
Medroxyprogesterone | GRP-19676 | Tablet containing medroxyprogesterone acetate 10 mg | Oral | Provera |
Medroxyprogesterone | GRP-19872 | Tablet containing medroxyprogesterone acetate 5 mg | Oral | Provera |
Medroxyprogesterone | GRP-28650 | Injection containing medroxyprogesterone acetate 150 mg in 1 mL | Injection | Depo-Provera |
Medroxyprogesterone | GRP-28650 | Injection containing medroxyprogesterone acetate 150 mg in 1 mL pre-filled syringe | Injection | Depo-Provera |
Mefenamic acid | GRP-25998 | Capsule 250 mg | Oral | FEMIN |
Meloxicam | GRP-15468 | Capsule 15 mg | Oral | APO-Meloxicam |
Meloxicam | GRP-15468 | Tablet 15 mg | Oral | APX-Meloxicam |
Meloxicam | GRP-15658 | Capsule 7.5 mg | Oral | APO-Meloxicam |
Meloxicam | GRP-15658 | Tablet 7.5 mg | Oral | APX-Meloxicam |
Memantine | GRP-20090 | Tablet containing memantine hydrochloride 10 mg | Oral | APO-Memantine |
Memantine | GRP-19971 | Tablet containing memantine hydrochloride 20 mg | Oral | APO-Memantine |
Mercaptopurine | GRP-23857 | Tablet containing mercaptopurine monohydrate 50 mg | Oral | MERCAPTOPURINE-LINK |
Mesalazine | GRP-27214 | Tablet 1.2 g (prolonged release) | Oral | Mesalazine 1.2 TAKEDA |
Metformin | GRP-19608 | Tablet (extended release) containing metformin hydrochloride 1 g | Oral | APO-Metformin XR 1000 |
Metformin | GRP-24200 | Tablet (extended release) containing metformin hydrochloride 500 mg | Oral | APO-Metformin XR 500 |
Metformin | GRP-19944 | Tablet containing metformin hydrochloride 1 g | Oral | APX-Metformin |
Metformin | GRP-19880 | Tablet containing metformin hydrochloride 500 mg | Oral | APX-Metformin |
Metformin | GRP-19682 | Tablet containing metformin hydrochloride 850 mg | Oral | APX-Metformin |
Methadone | GRP-27523 | Oral liquid containing methadone hydrochloride 25 mg per 5 mL in 1 L bottle, 1 mL | Oral | Aspen Methadone Syrup |
Methadone | GRP-27510 | Oral liquid containing methadone hydrochloride 25 mg per 5 mL in 200 mL bottle, 1 mL | Oral | Aspen Methadone Syrup |
Methenamine | GRP-24551 | Tablet containing methenamine hippurate 1 g | Oral | Hiprex |
Methotrexate | GRP-27896 | Tablet 10 mg | Oral | ARX-Methotrexate |
Methotrexate | GRP-19736 | Tablet 2.5 mg | Oral | ARX-Methotrexate |
Methyldopa | GRP-19840 | Tablet 250 mg (as sesquihydrate) | Oral | Aldomet |
Methylphenidate | GRP-27210 | Capsule containing methylphenidate hydrochloride 10 mg (modified release) | Oral | Ritalin LA |
Methylphenidate | GRP-27215 | Capsule containing methylphenidate hydrochloride 20 mg (modified release) | Oral | Ritalin LA |
Methylphenidate | GRP-27209 | Capsule containing methylphenidate hydrochloride 30 mg (modified release) | Oral | Ritalin LA |
Methylphenidate | GRP-27206 | Capsule containing methylphenidate hydrochloride 40 mg (modified release) | Oral | Ritalin LA |
Methylphenidate | GRP-27208 | Capsule containing methylphenidate hydrochloride 60 mg (modified release) | Oral | Ritalin LA |
Methylphenidate | GRP-21745 | Tablet containing methylphenidate hydrochloride 10 mg | Oral | Artige |
Methylphenidate | GRP-25885 | Tablet containing methylphenidate hydrochloride 18 mg (extended release) | Oral | Concerta |
Methylphenidate | GRP-25859 | Tablet containing methylphenidate hydrochloride 27 mg (extended release) | Oral | Concerta |
Methylphenidate | GRP-25891 | Tablet containing methylphenidate hydrochloride 36 mg (extended release) | Oral | Concerta |
Methylphenidate | GRP-25892 | Tablet containing methylphenidate hydrochloride 54 mg (extended release) | Oral | Concerta |
Methylprednisolone | GRP-27997 | Cream containing methylprednisolone aceponate 1 mg per g, 15 g | Application | Advantan |
Methylprednisolone | GRP-27888 | Fatty ointment containing methylprednisolone aceponate 1 mg per g, 15 g | Application | Advantan (Fatty) |
Methylprednisolone | GRP-20006 | Injection containing methylprednisolone acetate 40 mg in 1 mL | Injection | Depo-Medrol |
Methylprednisolone | GRP-27999 | Ointment containing methylprednisolone aceponate 1 mg per g, 15 g | Application | Advantan |
Methylprednisolone | GRP-19893 | Powder for injection 1 g (as sodium succinate) | Injection | Methylpred |
Methylprednisolone | GRP-15597 | Powder for injection 40 mg (as sodium succinate) (S19A) | Injection | Solu-Medrone |
Methylprednisolone | GRP-15597 | Powder for injection 40 mg (as sodium succinate) with diluent | Injection | Solu-Medrol |
Metoclopramide | GRP-20027 | Tablet containing 10 mg metoclopramide hydrochloride (as monohydrate) | Oral | APO-Metoclopramide |
Metoprolol | GRP-19804 | Tablet containing metoprolol tartrate 100 mg | Oral | APO-Metoprolol |
Metoprolol | GRP-27677 | Tablet containing metoprolol tartrate 50 mg | Oral | APO-Metoprolol |
Metoprolol succinate | GRP-19594 | Tablet 190 mg (controlled release) | Oral | Metrol-XL 190 |
Metoprolol succinate | GRP-19596 | Tablet 23.75 mg (controlled release) | Oral | Metrol-XL 23.75 |
Metoprolol succinate | GRP-19592 | Tablet 47.5 mg (controlled release) | Oral | Metrol-XL 47.5 |
Metoprolol succinate | GRP-19595 | Tablet 95 mg (controlled release) | Oral | Metrol-XL 95 |
Metronidazole | GRP-20212 | Tablet 400 mg | Oral | Flagyl |
Minocycline | GRP-19899 | Tablet 50 mg (as hydrochloride) | Oral | Akamin 50 |
Mirtazapine | GRP-19718 | Tablet 15 mg | Oral | APX-Mirtazapine |
Mirtazapine | GRP-19628 | Tablet 30 mg | Oral | APX-Mirtazapine |
Mirtazapine | GRP-19763 | Tablet 45 mg | Oral | APX-Mirtazapine |
Moclobemide | GRP-19630 | Tablet 150 mg | Oral | Amira 150 |
Moclobemide | GRP-19932 | Tablet 300 mg | Oral | Amira 300 |
Modafinil | GRP-20604 | Tablet 100 mg | Oral | APO-Modafinil |
Mometasone | GRP-19924 | Cream containing mometasone furoate 1 mg per g, 15 g | Application | Elocon Alcohol Free |
Mometasone | GRP-19629 | Lotion containing mometasone furoate 1 mg per g, 30 mL | Application | Elocon |
Mometasone | GRP-19755 | Ointment containing mometasone furoate 1 mg per g, 15 g | Application | Elocon |
Montelukast | GRP-19556 | Tablet, chewable, 4 mg (as sodium) | Oral | MONTELAIR 4 |
Montelukast | GRP-19572 | Tablet, chewable, 5 mg (as sodium) | Oral | MONTELAIR 5 |
Morphine | GRP-20890 | Injection containing morphine hydrochloride trihydrate 10 mg in 1 mL | Injection | Morphine Juno |
Morphine | GRP-20890 | Injection containing morphine sulfate pentahydrate 10 mg in 1 mL | Injection | MORPHINE SULFATE 10 mg/1 mL MEDSURGE |
Morphine | GRP-28763 | Oral solution containing morphine hydrochloride trihydrate 5 mg per mL, 1 mL | Oral | Ordine 5 |
Morphine | GRP-28763 | Oral solution containing morphine hydrochloride trihydrate 5 mg per mL, 1 mL (S19A) | Oral | RA-Morph (NZ) |
Morphine | GRP-28497 | Oral solution containing morphine hydrochloride trihydrate 10 mg per mL, 1 mL | Oral | Ordine 10 |
Morphine | GRP-28497 | Oral solution containing morphine hydrochloride trihydrate 10 mg per mL, 1 mL (RA-Morph)(S19A) | Oral | RA-Morph (NZ) |
Morphine | GRP-28497 | Oral solution containing morphine hydrochloride trihydrate 10 mg per mL, 1 mL (S19A) | Oral | Morphini HCl Streuli |
Morphine | GRP-28109 | Oral solution containing morphine hydrochloride trihydrate 2 mg per mL, 1 mL | Oral | Ordine 2 |
Morphine | GRP-28109 | Oral solution containing morphine sulfate 10 mg per 5 mL in 100 mL bottle, 1 mL (S19A) | Oral | Morphine Oral Solution (Martindale Pharma) 10 mg/5 mL |
Morphine | GRP-28109 | Oral solution containing morphine sulfate 10 mg per 5 mL in 300 mL bottle, 1 mL (S19A) | Oral | Morphine Oral Solution (Martindale Pharma) 10 mg/5 mL |
Morphine | GRP-28109 | Oral solution containing morphine sulfate 2 mg per mL in 100 mL bottle, 1 mL (S19A) | Oral | Morphine Sulfate (Hikma) 10 mg/5 mL (2 mg/mL) |
Morphine | GRP-28109 | Oral solution containing morphine sulfate 2 mg per mL in 500 mL bottle, 1 mL (S19A) | Oral | Morphine Sulfate (Hikma) 10 mg/5 mL (2 mg/mL) |
Morphine | GRP-19885 | Tablet containing morphine sulfate pentahydrate 10 mg (controlled release) | Oral | MORPHINE MR APOTEX |
Morphine | GRP-19730 | Tablet containing morphine sulfate pentahydrate 100 mg (controlled release) | Oral | MORPHINE MR APOTEX |
Morphine | GRP-19923 | Tablet containing morphine sulfate pentahydrate 30 mg (controlled release) | Oral | MORPHINE MR APOTEX |
Morphine | GRP-19707 | Tablet containing morphine sulfate pentahydrate 60 mg (controlled release) | Oral | MORPHINE MR APOTEX |
Moxonidine | GRP-22366 | Tablet 200 micrograms | Oral | APO-Moxonidine |
Moxonidine | GRP-22375 | Tablet 400 micrograms | Oral | APO-Moxonidine |
Mycophenolic acid | GRP-17217 | Capsule containing mycophenolate mofetil 250 mg | Oral | APO-Mycophenolate |
Mycophenolic acid | GRP-26876 | Powder for oral suspension containing mycophenolate mofetil 1 g per 5 mL, 165 mL | Oral | CellCept |
Mycophenolic acid | GRP-28293 | Tablet (enteric coated) containing mycophenolate sodium equivalent to 180 mg mycophenolic acid | Oral | Mycophenolic Acid ARX |
Mycophenolic acid | GRP-28115 | Tablet (enteric coated) containing mycophenolate sodium equivalent to 360 mg mycophenolic acid | Oral | Mycophenolic Acid ARX |
Mycophenolic acid | GRP-20011 | Tablet containing mycophenolate mofetil 500 mg | Oral | ARX-MYCOPHENOLATE |
Naloxone | GRP-21362 | Injection containing naloxone hydrochloride 400 micrograms in 1 mL ampoule | Injection | Naloxone Hydrochloride (DBL) |
Naloxone | GRP-27818 | Nasal spray 1.8 mg (as hydrochloride dihydrate) in 0.1 mL single dose unit, 2 | NASAL | Nyxoid |
Naloxone | GRP-27818 | Nasal spray 1.8 mg (as hydrochloride dihydrate) in 0.1 mL single dose unit, 2 (s19A) | NASAL | Nyxoid (UK) |
Naltrexone | GRP-19914 | Tablet containing naltrexone hydrochloride 50 mg | Oral | ARX-NALTREXONE |
Naproxen | GRP-20035 | Tablet 1 g (sustained release) | Oral | Naprosyn SR1000 |
Naproxen | GRP-20009 | Tablet 750 mg (sustained release) | Oral | Naprosyn SR750 |
Naproxen | GRP-20020 | Tablet containing naproxen sodium 550 mg | Oral | Anaprox 550 |
Nebivolol | GRP-22506 | Tablet 1.25 mg (as hydrochloride) | Oral | APO-Nebivolol |
Nebivolol | GRP-22512 | Tablet 10 mg (as hydrochloride) | Oral | APO-Nebivolol |
Nebivolol | GRP-22511 | Tablet 5 mg (as hydrochloride) | Oral | APO-Nebivolol |
Nevirapine | GRP-19845 | Tablet 200 mg | Oral | Nevirapine Alphapharm |
Nicorandil | GRP-19964 | Tablets 10 mg, 60 | Oral | APO-Nicorandil |
Nicorandil | GRP-19963 | Tablets 20 mg, 60 | Oral | APO-Nicorandil |
Nifedipine | GRP-19687 | Tablet 30 mg (controlled release) | Oral | Addos XR 30 |
Nifedipine | GRP-19801 | Tablet 60 mg (controlled release) | Oral | Addos XR 60 |
Niraparib | GRP-28761 | Capsule 100 mg (as tosilate monohydrate) | Oral | Zejula |
Niraparib | GRP-28761 | Tablet 100 mg (as tosilate monohydrate) | Oral | Zejula |
Nitrazepam | GRP-20002 | Tablet 5 mg | Oral | Alodorm |
Nitrofurantoin | GRP-24202 | Capsule 100 mg | Oral | ARX-Nitrofurantoin |
Nitrofurantoin | GRP-25565 | Capsule 50 mg | Oral | ARX-Nitrofurantoin |
Nizatidine | GRP-19784 | Capsule 150 mg | Oral | Nizac |
Nizatidine | GRP-19651 | Capsule 300 mg | Oral | Nizac |
Norfloxacin | GRP-19724 | Tablet 400 mg | Oral | APO-Norfloxacin |
Nortriptyline | GRP-21641 | Tablet 10 mg (as hydrochloride) | Oral | Allegron |
Nortriptyline | GRP-21633 | Tablet 25 mg (as hydrochloride) | Oral | Allegron |
Octreotide | GRP-17613 | Injection (modified release) 10 mg (as acetate), vial and diluent syringe | Injection | Octreotide Depot |
Octreotide | GRP-17622 | Injection (modified release) 20 mg (as acetate), vial and diluent syringe | Injection | Octreotide Depot |
Octreotide | GRP-17615 | Injection (modified release) 30 mg (as acetate), vial and diluent syringe | Injection | Octreotide Depot |
Octreotide | GRP-20282 | Injection 100 micrograms (as acetate) in 1 mL | Injection | Octreotide (SUN) |
Octreotide | GRP-20282 | Injection 100 micrograms (as acetate) in 1 mL (S19A) | Injection | Octreotide Acetate Omega (Canada) |
Octreotide | GRP-20060 | Injection 50 micrograms (as acetate) in 1 mL | Injection | Octreotide (SUN) |
Octreotide | GRP-20060 | Injection 50 micrograms (as acetate) in 1 mL (S19A) | Injection | Octreotide Acetate Omega (Canada) |
Octreotide | GRP-20085 | Injection 500 micrograms (as acetate) in 1 mL | Injection | Octreotide (SUN) |
Olanzapine | GRP-15921 | Tablet 5 mg | Oral | NOUMED OLANZAPINE |
Olanzapine | GRP-15513 | Tablet 10 mg | Oral | APO-OLANZAPINE |
Olanzapine | GRP-15723 | Tablet 10 mg (orally disintegrating) | Oral | APO-Olanzapine ODT |
Olanzapine | GRP-15723 | Wafer 10 mg | Oral | Zyprexa Zydis |
Olanzapine | GRP-15953 | Tablet 15 mg (orally disintegrating) | Oral | APO-Olanzapine ODT |
Olanzapine | GRP-15953 | Wafer 15 mg | Oral | Zyprexa Zydis |
Olanzapine | GRP-15492 | Tablet 2.5 mg | Oral | APO-OLANZAPINE |
Olanzapine | GRP-15643 | Tablet 20 mg (orally disintegrating) | Oral | APO-Olanzapine ODT |
Olanzapine | GRP-15643 | Wafer 20 mg | Oral | Zyprexa Zydis |
Olanzapine | GRP-15797 | Tablet 5 mg (orally disintegrating) | Oral | APO-Olanzapine ODT |
Olanzapine | GRP-15797 | Wafer 5 mg | Oral | Zyprexa Zydis |
Olanzapine | GRP-15884 | Tablet 7.5 mg | Oral | APO-OLANZAPINE |
Olmesartan | GRP-21158 | Tablet containing olmesartan medoxomil 20 mg | Oral | APO-Olmesartan |
Olmesartan | GRP-21168 | Tablet containing olmesartan medoxomil 40 mg | Oral | APO-Olmesartan |
Olmesartan with amlodipine | GRP-21156 | Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) | Oral | OLMEKAR |
Olmesartan with amlodipine | GRP-21157 | Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) | Oral | OLMEKAR |
Olmesartan with amlodipine | GRP-21160 | Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) | Oral | OLMEKAR |
Olmesartan with amlodipine and hydrochlorothiazide | GRP-23701 | Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral | APO-Olmesartan/Amlodipine/HCTZ 20/5/12.5 |
Olmesartan with amlodipine and hydrochlorothiazide | GRP-23700 | Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral | APO-Olmesartan/Amlodipine/HCTZ 40/10/12.5 |
Olmesartan with amlodipine and hydrochlorothiazide | GRP-23710 | Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 25 mg | Oral | APO-Olmesartan/Amlodipine/HCTZ 40/10/25 |
Olmesartan with amlodipine and hydrochlorothiazide | GRP-23703 | Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral | APO-Olmesartan/Amlodipine/HCTZ 40/5/12.5 tablet |
Olmesartan with amlodipine and hydrochlorothiazide | GRP-23699 | Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 25 mg | Oral | APO-Olmesartan/Amlodipine/HCTZ 40/5/25 tablet |
Olmesartan with hydrochlorothiazide | GRP-21155 | Tablet containing olmesartan medoxomil 20 mg with hydrochlorothiazide 12.5 mg | Oral | APO-Olmesartan/HCTZ 20/12.5 |
Olmesartan with hydrochlorothiazide | GRP-21154 | Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 12.5 mg | Oral | APO-Olmesartan/HCTZ 40/12.5 |
Olmesartan with hydrochlorothiazide | GRP-21161 | Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 25 mg | Oral | APO-Olmesartan/HCTZ 40/25 |
Omeprazole | GRP-14650 | Capsule 20 mg | Oral | APO-Omeprazole |
Omeprazole | GRP-14650 | Tablet 20 mg | Oral | APO-Omeprazole |
Omeprazole | GRP-14650 | Tablet 20 mg (as magnesium) | Oral | Acimax Tablets |
Ondansetron | GRP-15983 | Tablet (orally disintegrating) 4 mg | Oral | APX-Ondansetron ODT |
Ondansetron | GRP-15402 | Tablet (orally disintegrating) 8 mg | Oral | APX-Ondansetron ODT |
Ondansetron | GRP-19791 | Tablet 4 mg (as hydrochloride dihydrate) | Oral | APO-Ondansetron |
Ondansetron | GRP-19626 | Tablet 8 mg (as hydrochloride dihydrate) | Oral | APO-Ondansetron |
Ondansetron | GRP-15983 | Wafer 4 mg | Oral | Zofran Zydis |
Ondansetron | GRP-15402 | Wafer 8 mg | Oral | Zofran Zydis |
Oxazepam | GRP-20046 | Tablet 15 mg | Oral | Alepam 15 |
Oxazepam | GRP-19993 | Tablet 30 mg | Oral | Alepam 30 |
Oxycodone | GRP-19610 | Tablet containing oxycodone hydrochloride 10 mg (controlled release) | Oral | Oxycodone Sandoz |
Oxycodone | GRP-19619 | Tablet containing oxycodone hydrochloride 20 mg (controlled release) | Oral | Oxycodone Sandoz |
Oxycodone | GRP-19617 | Tablet containing oxycodone hydrochloride 40 mg (controlled release) | Oral | Oxycodone Sandoz |
Oxycodone | GRP-22722 | Tablet containing oxycodone hydrochloride 5 mg | Oral | ENDONE |
Oxycodone | GRP-19609 | Tablet containing oxycodone hydrochloride 80 mg (controlled release) | Oral | Oxycodone Sandoz |
Palonosetron | GRP-26174 | Injection 250 micrograms (as hydrochloride) in 5 mL | Injection | Aloxi |
Pantoprazole | GRP-19833 | Tablet (enteric coated) 20 mg (as sodium sesquihydrate) | Oral | APO-Pantoprazole |
Pantoprazole | GRP-20087 | Tablet (enteric coated) 40 mg (as sodium sesquihydrate) | Oral | APO-Pantoprazole |
Paracetamol | GRP-20761 | Tablet 665 mg (modified release) | Oral | APOHEALTH Osteo Relief Paracetamol 665 mg |
Paracetamol | GRP-20015 | Tablet 500 mg | Oral | APO-Paracetamol |
Paroxetine | GRP-15790 | Tablet 20 mg (as hydrochloride) | Oral | APO-Paroxetine |
Pegfilgrastim | GRP-21364 | Injection 6 mg in 0.6 mL single use pre-filled syringe | Injection | Pelgraz |
Perindopril | GRP-15525 | Tablet containing perindopril arginine 10 mg | Oral | APO-Perindopril Arginine |
Perindopril | GRP-15965 | Tablet containing perindopril arginine 2.5 mg | Oral | APO-Perindopril Arginine |
Perindopril | GRP-15442 | Tablet containing perindopril arginine 5 mg | Oral | APO-Perindopril Arginine |
Perindopril | GRP-15965 | Tablet containing perindopril erbumine 2 mg | Oral | APO-Perindopril |
Perindopril | GRP-15442 | Tablet containing perindopril erbumine 4 mg | Oral | APO-Perindopril |
Perindopril | GRP-15525 | Tablet containing perindopril erbumine 8 mg | Oral | APO-Perindopril |
Perindopril with amlodipine | GRP-19627 | Tablet containing 10 mg perindopril arginine with 10 mg amlodipine (as besilate) | Oral | APO-Perindopril Arginine/Amlodipine 10/10 |
Perindopril with amlodipine | GRP-19798 | Tablet containing 10 mg perindopril arginine with 5 mg amlodipine (as besilate) | Oral | APO-Perindopril Arginine/Amlodipine 10/5 |
Perindopril with amlodipine | GRP-19886 | Tablet containing 5 mg perindopril arginine with 10 mg amlodipine (as besilate) | Oral | APO-Perindopril Arginine/Amlodipine 5/10 |
Perindopril with amlodipine | GRP-19936 | Tablet containing 5 mg perindopril arginine with 5 mg amlodipine (as besilate) | Oral | APO-Perindopril Arginine/Amlodipine 5/5 |
Perindopril with indapamide | GRP-21205 | Tablet containing perindopril arginine 2.5 mg with indapamide hemihydrate 0.625 mg | Oral | Coversyl Plus LD 2.5mg/0.625mg |
Perindopril with indapamide | GRP-15765 | Tablet containing perindopril arginine 5 mg with indapamide hemihydrate 1.25 mg | Oral | Coversyl Plus 5mg/1.25mg |
Perindopril with indapamide | GRP-15765 | Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg | Oral | APO-Perindopril/Indapamide |
Pioglitazone | GRP-19814 | Tablet 15 mg (as hydrochloride) | Oral | Acpio 15 |
Pioglitazone | GRP-19943 | Tablet 30 mg (as hydrochloride) | Oral | Acpio 30 |
Pioglitazone | GRP-19790 | Tablet 45 mg (as hydrochloride) | Oral | Acpio 45 |
Pirfenidone | GRP-27890 | Tablet 267 mg | Oral | Pirfenidet |
Pirfenidone | GRP-27892 | Tablet 801mg | Oral | Pirfenidet |
Plerixafor | GRP-26646 | Injection 24 mg in 1.2 mL | Injection | Mozobil |
Polyethylene glycol 400 with propylene glycol | GRP-26947 | Eye drops 4 mg-3 mg per mL, 15 mL | Application to the eye | Optix |
Posaconazole | GRP-24439 | Tablet (modified release) 100 mg | Oral | Pharmacor Posaconazole |
Pramipexole | GRP-20534 | Tablet (extended release) containing pramipexole dihydrochloride monohydrate 1.5 mg | Oral | APO-Pramipexole ER |
Pramipexole | GRP-20530 | Tablet (extended release) containing pramipexole dihydrochloride monohydrate 2.25 mg | Oral | APO-Pramipexole ER |
Pramipexole | GRP-20533 | Tablet (extended release) containing pramipexole dihydrochloride monohydrate 3 mg | Oral | APO-Pramipexole ER |
Pramipexole | GRP-20535 | Tablet (extended release) containing pramipexole dihydrochloride monohydrate 3.75 mg | Oral | APO-Pramipexole ER |
Pramipexole | GRP-20529 | Tablet (extended release) containing pramipexole dihydrochloride monohydrate 375 micrograms | Oral | APO-Pramipexole ER |
Pramipexole | GRP-20532 | Tablet (extended release) containing pramipexole dihydrochloride monohydrate 4.5 mg | Oral | APO-Pramipexole ER |
Pramipexole | GRP-20531 | Tablet (extended release) containing pramipexole dihydrochloride monohydrate 750 micrograms | Oral | APO-Pramipexole ER |
Pramipexole | GRP-19734 | Tablet containing pramipexole dihydrochloride monohydrate 1 mg | Oral | APO-Pramipexole |
Pramipexole | GRP-19836 | Tablet containing pramipexole dihydrochloride monohydrate 125 micrograms | Oral | APO-Pramipexole |
Pramipexole | GRP-19688 | Tablet containing pramipexole dihydrochloride monohydrate 250 micrograms | Oral | APO-Pramipexole |
Pravastatin | GRP-20171 | Tablet containing pravastatin sodium 10 mg | Oral | APX-Pravastatin |
Pravastatin | GRP-20150 | Tablet containing pravastatin sodium 20 mg | Oral | APX-Pravastatin |
Pravastatin | GRP-20079 | Tablet containing pravastatin sodium 40 mg | Oral | APX-Pravastatin |
Pravastatin | GRP-20082 | Tablet containing pravastatin sodium 80 mg | Oral | APX-Pravastatin |
Prazosin | GRP-19942 | Tablet 1 mg (as hydrochloride) | Oral | APO-Prazosin |
Prazosin | GRP-19831 | Tablet 2 mg (as hydrochloride) | Oral | APO-Prazosin |
Prazosin | GRP-19871 | Tablet 5 mg (as hydrochloride) | Oral | APO-Prazosin |
Prednisolone | GRP-19768 | Oral solution 5 mg (as sodium phosphate) per mL, 30 mL | Oral | PredMix |
Prednisolone | GRP-19757 | Tablet 1 mg | Oral | Panafcortelone |
Prednisone | GRP-19658 | Tablet 1 mg | Oral | Panafcort |
Pregabalin | GRP-21640 | Capsule 150 mg | Oral | APO-Pregabalin |
Pregabalin | GRP-21642 | Capsule 25 mg | Oral | APO-Pregabalin |
Pregabalin | GRP-21628 | Capsule 300 mg | Oral | APO-Pregabalin |
Pregabalin | GRP-21634 | Capsule 75 mg | Oral | APO-Pregabalin |
Prochlorperazine | GRP-28600 | Tablet containing prochlorperazine maleate 5 mg | Oral | APO-Prochlorperazine |
Prochlorperazine | GRP-28600 | Tablet containing prochlorperazine maleate 5 mg (S19A) | Oral | Stemetil (Ireland) |
Propranolol | GRP-20376 | Tablet containing propranolol hydrochloride 10 mg | Oral | APO-Propranolol |
Propranolol | GRP-20367 | Tablet containing propranolol hydrochloride 40 mg | Oral | APO-Propranolol |
Quetiapine | GRP-21163 | Tablet (modified release) 150 mg (as fumarate) | Oral | APX-Quetiapine XR |
Quetiapine | GRP-20702 | Tablet (modified release) 200 mg (as fumarate) | Oral | APX-Quetiapine XR |
Quetiapine | GRP-20713 | Tablet (modified release) 300 mg (as fumarate) | Oral | APX-Quetiapine XR |
Quetiapine | GRP-20726 | Tablet (modified release) 400 mg (as fumarate) | Oral | APX-Quetiapine XR |
Quetiapine | GRP-20779 | Tablet (modified release) 50 mg (as fumarate) | Oral | APX-Quetiapine XR |
Quetiapine | GRP-19767 | Tablet 100 mg (as fumarate) | Oral | APX-QUETIAPINE |
Quetiapine | GRP-19709 | Tablet 200 mg (as fumarate) | Oral | APX-QUETIAPINE |
Quetiapine | GRP-19935 | Tablet 25 mg (as fumarate) | Oral | APX-QUETIAPINE |
Quetiapine | GRP-19663 | Tablet 300 mg (as fumarate) | Oral | APX-QUETIAPINE |
Quinapril | GRP-19902 | Tablet 10 mg (as hydrochloride) | Oral | Accupril |
Quinapril | GRP-19716 | Tablet 20 mg (as hydrochloride) | Oral | Accupril |
Quinapril | GRP-19789 | Tablet 5 mg (as hydrochloride) | Oral | Accupril |
Rabeprazole | GRP-19921 | Tablet containing rabeprazole sodium 10 mg (enteric coated) | Oral | APO-Rabeprazole |
Rabeprazole | GRP-20107 | Tablet containing rabeprazole sodium 20 mg (enteric coated) | Oral | APO-Rabeprazole |
Raloxifene | GRP-19622 | Tablet containing raloxifene hydrochloride 60 mg | Oral | Evista |
Ramipril | GRP-15640 | Capsule 1.25 mg | Oral | Tryzan Caps 1.25 |
Ramipril | GRP-15431 | Capsule 10 mg | Oral | APO-Ramipril |
Ramipril | GRP-15769 | Capsule 2.5 mg | Oral | APO-Ramipril |
Ramipril | GRP-15424 | Capsule 5 mg | Oral | APO-Ramipril |
Ramipril | GRP-15640 | Tablet 1.25 mg | Oral | Prilace |
Ramipril | GRP-15431 | Tablet 10 mg | Oral | APO-Ramipril |
Ramipril | GRP-15769 | Tablet 2.5 mg | Oral | APO-Ramipril |
Ramipril | GRP-15424 | Tablet 5 mg | Oral | APO-Ramipril |
Ranibizumab | GRP-17312 | Solution for intravitreal injection 1.65 mg in 0.165 mL pre-filled syringe | Injection | Lucentis |
Ranibizumab | GRP-17312 | Solution for intravitreal injection 2.3 mg in 0.23 mL | Injection | Lucentis |
Rasagiline | GRP-22819 | Tablet 1 mg (as mesilate) | Oral | Alziras |
Riluzole | GRP-19669 | Tablet 50 mg | Oral | APO-Riluzole |
Risedronic acid | GRP-19671 | Tablet containing risedronate sodium 150 mg | Oral | Actonel Once-a-Month |
Risedronic acid | GRP-19983 | Tablet containing risedronate sodium 35 mg | Oral | APO-Risedronate |
Risperidone | GRP-24014 | Oral solution 1 mg per mL, 100 mL | Oral | Risperdal |
Risperidone | GRP-14646 | Tablet 0.5 mg | Oral | APO-Risperidone |
Risperidone | GRP-20120 | Tablet 1 mg | Oral | APO-Risperidone |
Risperidone | GRP-20017 | Tablet 2 mg | Oral | APO-Risperidone |
Risperidone | GRP-19938 | Tablet 3 mg | Oral | APO-Risperidone |
Risperidone | GRP-19844 | Tablet 4 mg | Oral | APO-Risperidone |
Rituximab | GRP-26547 | Solution for I.V. infusion 100 mg in 10 mL | Injection | Riximyo |
Rituximab | GRP-26545 | Solution for I.V. infusion 500 mg in 50 mL | Injection | Riximyo |
Rizatriptan | GRP-17623 | Tablet (orally disintegrating) 10 mg (as benzoate) | Oral | APO-Rizatriptan |
Rizatriptan | GRP-17623 | Wafer 10 mg (as benzoate) | Oral | Maxalt |
Rosuvastatin | GRP-19558 | Tablet 10 mg (as calcium) | Oral | APO-Rosuvastatin |
Rosuvastatin | GRP-19557 | Tablet 20 mg (as calcium) | Oral | APO-ROSUVASTATIN |
Rosuvastatin | GRP-19562 | Tablet 40 mg (as calcium) | Oral | APO-ROSUVASTATIN |
Rosuvastatin | GRP-19569 | Tablet 5 mg (as calcium) | Oral | APX-Rosuvastatin |
Roxithromycin | GRP-20052 | Tablet 150 mg | Oral | APO-Roxithromycin |
Roxithromycin | GRP-20144 | Tablet 300 mg | Oral | APO-Roxithromycin |
Salbutamol | GRP-21535 | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 | Inhalation | Ventolin Nebules |
Salbutamol | GRP-21535 | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 (S19A) | Inhalation | pms-SALBUTAMOL |
Salbutamol | GRP-21535 | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30 | Inhalation | Salbutamol Cipla |
Salbutamol | GRP-21361 | Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20 | Inhalation | Ventolin Nebules |
Salbutamol | GRP-21361 | Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30 | Inhalation | Salbutamol Cipla |
Salbutamol | GRP-24210 | Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation) | Inhalation by mouth | Asmol CFC-Free with dose counter |
Sertraline | GRP-24880 | Tablet 100 mg (as hydrochloride) | Oral | APO-Sertraline |
Sertraline | GRP-24879 | Tablet 50 mg (as hydrochloride) | Oral | APO-Sertraline |
Sevelamer | GRP-23578 | Tablet containing sevelamer carbonate 800 mg | Oral | ARX-SEVELAMER |
Sevelamer | GRP-23578 | Tablet containing sevelamer hydrochloride 800 mg | Oral | Renagel |
Sildenafil | GRP-20013 | Tablet 20 mg (as citrate) | Oral | Revatio |
Simvastatin | GRP-19982 | Tablet 10 mg | Oral | APO-Simvastatin |
Simvastatin | GRP-19996 | Tablet 20 mg | Oral | APO-Simvastatin |
Simvastatin | GRP-19986 | Tablet 40 mg | Oral | APO-Simvastatin |
Simvastatin | GRP-20221 | Tablet 5 mg | Oral | Simvastatin Sandoz |
Simvastatin | GRP-20109 | Tablet 80 mg | Oral | APO-Simvastatin |
Sitagliptin | GRP-26498 | Tablet 100 mg | Oral | Januvia |
Sitagliptin | GRP-26497 | Tablet 25 mg | Oral | Januvia |
Sitagliptin | GRP-26493 | Tablet 50 mg | Oral | Januvia |
Sitagliptin with metformin | GRP-28131 | Tablet (modified release) containing 100 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Janumet XR |
Sitagliptin with metformin | GRP-28124 | Tablet (modified release) containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Janumet XR |
Sitagliptin with metformin | GRP-26459 | Tablet containing 50 mg sitagliptin with 1000 mg metformin hydrochloride | Oral | Janumet |
Sitagliptin with metformin | GRP-26451 | Tablet containing 50 mg sitagliptin with 500 mg metformin hydrochloride | Oral | Janumet |
Sitagliptin with metformin | GRP-26454 | Tablet containing 50 mg sitagliptin with 850 mg metformin hydrochloride | Oral | Janumet |
Sotalol | GRP-19704 | Tablet containing sotalol hydrochloride 160 mg | Oral | APX-Sotalol |
Sotalol | GRP-19874 | Tablet containing sotalol hydrochloride 80 mg | Oral | APX-Sotalol |
Spironolactone | GRP-19653 | Tablet 100 mg | Oral | Aldactone |
Spironolactone | GRP-19873 | Tablet 25 mg | Oral | Aldactone |
Sulfasalazine | GRP-20028 | Tablet 500 mg (enteric coated) | Oral | Pyralin EN |
Sumatriptan | GRP-15928 | Tablet (fast disintegrating) 50 mg (as succinate) | Oral | Imigran FDT |
Sumatriptan | GRP-15928 | Tablet 50 mg (as succinate) | Oral | APO-Sumatriptan |
Sunitinib | GRP-25561 | Capsule 12.5 mg | Oral | Sunitinib MSN |
Sunitinib | GRP-25554 | Capsule 25 mg | Oral | ARX-Sunitinib |
Sunitinib | GRP-25556 | Capsule 37.5 mg | Oral | ARX-Sunitinib |
Sunitinib | GRP-25553 | Capsule 50 mg | Oral | ARX-Sunitinib |
Tacrolimus | GRP-20053 | Capsule 0.5 mg | Oral | Pacrolim |
Tacrolimus | GRP-20892 | Capsule 0.5 mg (once daily prolonged release) | Oral | ADVAGRAF XL |
Tacrolimus | GRP-19985 | Capsule 1 mg | Oral | Pacrolim |
Tacrolimus | GRP-20891 | Capsule 1 mg (once daily prolonged release) | Oral | ADVAGRAF XL |
Tacrolimus | GRP-28602 | Capsule 3 mg (once daily prolonged release) | Oral | ADVAGRAF XL |
Tacrolimus | GRP-20076 | Capsule 5 mg | Oral | Pharmacor Tacrolimus 5 |
Tacrolimus | GRP-20887 | Capsule 5 mg (once daily prolonged release) | Oral | ADVAGRAF XL |
Tadalafil | GRP-24271 | Tablet 20 mg | Oral | Adcirca |
Tamoxifen | GRP-15405 | Tablet 20 mg (as citrate) | Oral | Genox 20 |
Telmisartan | GRP-19604 | Tablet 40 mg | Oral | APO-Telmisartan |
Telmisartan | GRP-19601 | Tablet 80 mg | Oral | APO-Telmisartan |
Telmisartan with amlodipine | GRP-19588 | Tablet 40 mg-10 mg (as besilate) | Oral | Pritor/Amlodipine |
Telmisartan with amlodipine | GRP-19587 | Tablet 40 mg-5 mg (as besilate) | Oral | Pritor/Amlodipine |
Telmisartan with amlodipine | GRP-19589 | Tablet 80 mg-10 mg (as besilate) | Oral | Pritor/Amlodipine |
Telmisartan with amlodipine | GRP-19590 | Tablet 80 mg-5 mg (as besilate) | Oral | Pritor/Amlodipine |
Telmisartan with hydrochlorothiazide | GRP-19555 | Tablet 40 mg-12.5 mg | Oral | APO-Telmisartan HCTZ 40/12.5 |
Telmisartan with hydrochlorothiazide | GRP-19561 | Tablet 80 mg-12.5 mg | Oral | APO-Telmisartan HCTZ 80/12.5 |
Telmisartan with hydrochlorothiazide | GRP-19571 | Tablet 80 mg-25 mg | Oral | APO-Telmisartan HCTZ 80/25 |
Temazepam | GRP-19980 | Tablet 10 mg | Oral | APO-Temazepam |
Temozolomide | GRP-20268 | Capsule 100 mg | Oral | APO-Temozolomide |
Temozolomide | GRP-20068 | Capsule 140 mg | Oral | APO-Temozolomide |
Temozolomide | GRP-20004 | Capsule 180 mg | Oral | APO-Temozolomide |
Temozolomide | GRP-19977 | Capsule 20 mg | Oral | APO-Temozolomide |
Temozolomide | GRP-19803 | Capsule 250 mg | Oral | APO-Temozolomide |
Temozolomide | GRP-19997 | Capsule 5 mg | Oral | APO-Temozolomide |
Tenecteplase | GRP-26656 | Powder for injection 50 mg with solvent | Injection | Metalyse |
Tenecteplase | GRP-26656 | Powder for injection 50 mg with solvent (s19A) | Injection | TNKase (Canada) |
Tenofovir | GRP-21636 | Tablet containing tenofovir disoproxil fumarate 300 mg | Oral | Tenofovir APOTEX |
Tenofovir | GRP-21636 | Tablet containing tenofovir disoproxil maleate 300 mg | Oral | Tenofovir Disoproxil Mylan |
Tenofovir | GRP-21636 | Tablet containing tenofovir disoproxil phosphate 291 mg | Oral | Tenofovir GH |
Tenofovir with emtricitabine | GRP-21638 | Tablet containing tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg | Oral | CIPLA TENOFOVIR + EMTRICITABINE 300/200 |
Tenofovir with emtricitabine | GRP-21638 | Tablet containing tenofovir disoproxil maleate 300 mg with emtricitabine 200 mg | Oral | Tenofovir Disoproxil Emtricitabine Viatris 300/200 |
Tenofovir with emtricitabine | GRP-21638 | Tablet containing tenofovir disoproxil phosphate 291 mg with emtricitabine 200 mg | Oral | Tenofovir EMT GH |
Tenofovir with emtricitabine | GRP-21638 | Tablet containing tenofovir disoproxil succinate 301 mg with emtricitabine 200 mg | Oral | Tenofovir/Emtricitabine Sandoz 301/200 |
Terbinafine | GRP-20256 | Tablet 250 mg (as hydrochloride) | Oral | APO-Terbinafine |
Teriflunomide | GRP-23068 | Tablet 14 mg | Oral | APO-TERIFLUNOMIDE |
Teriparatide | GRP-25564 | Injection 250 micrograms per mL, 2.4 mL in multi-dose pre-filled pen | Injection | Teriparatide Lupin |
Testosterone | GRP-28648 | I.M. injection containing testosterone undecanoate 1,000 mg in 4 mL | Injection | Reandron 1000 |
Tetrabenazine | GRP-26950 | Tablet 25 mg | Oral | iNova Pharmaceuticals (Australia) Pty Ltd |
Tiotropium | GRP-23704 | Capsule containing powder for oral inhalation 13 micrograms (as bromide) (for use in Zonda device) | Inhalation by mouth | Braltus |
Tiotropium | GRP-23704 | Capsule containing powder for oral inhalation 18 micrograms (as bromide monohydrate) (for use in HandiHaler) | Inhalation by mouth | Spiriva |
Tirofiban | GRP-19593 | Solution concentrate for I.V. infusion 12.5 mg (as hydrochloride) in 50 mL | Injection | Aggrastat |
Tobramycin | GRP-20899 | Solution for inhalation 300 mg in 5 mL | Inhalation | Tobi |
Topiramate | GRP-19766 | Tablet 100 mg | Oral | APO-Topiramate |
Topiramate | GRP-19668 | Tablet 200 mg | Oral | APO-Topiramate |
Topiramate | GRP-19896 | Tablet 25 mg | Oral | APO-Topiramate |
Topiramate | GRP-19765 | Tablet 50 mg | Oral | APO-Topiramate |
Tramadol | GRP-20030 | Capsule containing tramadol hydrochloride 50 mg | Oral | APO-Tramadol |
Tramadol | GRP-20129 | Injection containing tramadol hydrochloride 100 mg in 2 mL | Injection | Tramadol AN |
Tramadol | GRP-19670 | Tablet (sustained release) containing tramadol hydrochloride 100 mg | Oral | APO-Tramadol SR |
Tramadol | GRP-19815 | Tablet (sustained release) containing tramadol hydrochloride 150 mg | Oral | APO-Tramadol SR |
Tramadol | GRP-19805 | Tablet (sustained release) containing tramadol hydrochloride 200 mg | Oral | APO-Tramadol SR |
Trandolapril | GRP-19830 | Capsule 1 mg | Oral | Dolapril 1 |
Trandolapril | GRP-19654 | Capsule 2 mg | Oral | Dolapril 2 |
Trandolapril | GRP-19912 | Capsule 4 mg | Oral | Dolapril 4 |
Trandolapril | GRP-19735 | Capsule 500 micrograms | Oral | Dolapril 0.5 |
Tranexamic acid | GRP-21497 | Tablet 500 mg | Oral | APO-Tranexamic Acid |
Triamcinolone | GRP-19745 | Cream containing triamcinolone acetonide 200 micrograms per g, 100 g | Application | Aristocort 0.02% |
Triamcinolone | GRP-19701 | Ointment containing triamcinolone acetonide 200 micrograms per g, 100 g | Application | Aristocort 0.02% |
Triamcinolone with neomycin, gramicidin and nystatin | GRP-19728 | Ear drops containing triamcinolone acetonide 0.9 mg with neomycin 2.25 mg (as sulfate), gramicidin 225 micrograms and nystatin 90,000 units per mL, 7.5 mL | Application to the ear | Kenacomb Otic |
Triamcinolone with neomycin, gramicidin and nystatin | GRP-19681 | Ear ointment containing triamcinolone acetonide 1 mg with neomycin 2.5 mg (as sulfate), gramicidin 250 micrograms and nystatin 100,000 units per g, 5 g | Application to the ear | Kenacomb Otic |
Trientine | GRP-28298 | Capsule containing trientine dihydrochloride 250 mg (equivalent to 166.7 mg trientine) | Oral | Trientine Dr. Reddy's |
Trimethoprim | GRP-20308 | Tablet 300 mg | Oral | Alprim |
Trimethoprim with sulfamethoxazole | GRP-20094 | Tablet 160 mg-800 mg | Oral | Bactrim DS |
Ursodeoxycholic acid | GRP-19961 | Capsule 250 mg | Oral | APO-Ursodeoxycholic acid |
Valaciclovir | GRP-19726 | Tablet 500 mg (as hydrochloride) | Oral | APX-Valaciclovir |
Valganciclovir | GRP-21630 | Tablet 450 mg (as hydrochloride) | Oral | VALGANCICLOVIR HETERO |
Valproic acid | GRP-19751 | Tablet (enteric coated) containing sodium valproate 200 mg | Oral | APO-Sodium Valproate |
Valproic acid | GRP-19922 | Tablet (enteric coated) containing sodium valproate 500 mg | Oral | APO-Sodium Valproate |
Valsartan | GRP-19599 | Tablet 160 mg | Oral | Dilart |
Valsartan | GRP-19600 | Tablet 320 mg | Oral | Dilart |
Valsartan | GRP-19598 | Tablet 40 mg | Oral | Dilart |
Valsartan | GRP-19602 | Tablet 80 mg | Oral | Dilart |
Valsartan with hydrochlorothiazide | GRP-19612 | Tablet 160 mg-12.5 mg | Oral | Co-Diovan 160/12.5 |
Valsartan with hydrochlorothiazide | GRP-19966 | Tablet 160 mg-25 mg | Oral | Co-Diovan 160/25 |
Valsartan with hydrochlorothiazide | GRP-19614 | Tablet 320 mg-12.5 mg | Oral | Co-Diovan 320/12.5 |
Valsartan with hydrochlorothiazide | GRP-19615 | Tablet 320 mg-25 mg | Oral | Co-Diovan 320/25 |
Valsartan with hydrochlorothiazide | GRP-19965 | Tablet 80 mg-12.5 mg | Oral | Co-Diovan 80/12.5 |
Vancomycin | GRP-26946 | Capsule 125 mg (125,000 I.U.) (as hydrochloride) | Oral | Vancocin |
Vancomycin | GRP-26952 | Capsule 250 mg (250,000 I.U.) (as hydrochloride) | Oral | Vancocin |
Varenicline | GRP-27996 | Box containing 11 tablets 0.5 mg (as tartrate) and 14 tablets 1 mg (as tartrate) in the first pack and 28 tablets 1 mg (as tartrate) in the second pack | Oral | Champix |
Varenicline | GRP-26245 | Tablet 1 mg (as tartrate) | Oral | Champix |
Venlafaxine | GRP-19796 | Capsule (modified release) 150 mg (as hydrochloride) | Oral | APO-Venlafaxine XR |
Venlafaxine | GRP-19721 | Capsule (modified release) 37.5 mg (as hydrochloride) | Oral | Efexor-XR |
Venlafaxine | GRP-19797 | Capsule (modified release) 75 mg (as hydrochloride) | Oral | APO-Venlafaxine XR |
Verapamil | GRP-19760 | Tablet containing verapamil hydrochloride 180 mg (sustained release) | Oral | Cordilox 180 SR |
Verapamil | GRP-19780 | Tablet containing verapamil hydrochloride 240 mg (sustained release) | Oral | Cordilox SR |
Verapamil | GRP-19898 | Tablet containing verapamil hydrochloride 80 mg | Oral | Anpec 80 |
Vinorelbine | GRP-27405 | Capsule 20 mg (as tartrate) | Oral | Navelbine |
Vinorelbine | GRP-27399 | Capsule 30 mg (as tartrate) | Oral | Navelbine |
Voriconazole | GRP-20447 | Tablet 200 mg | Oral | Voriconazole Sandoz |
Voriconazole | GRP-20450 | Tablet 50 mg | Oral | Voriconazole Sandoz |
Ziprasidone | GRP-19574 | Capsule 20 mg (as hydrochloride) | Oral | Zeldox |
Ziprasidone | GRP-19575 | Capsule 40 mg (as hydrochloride) | Oral | Zeldox |
Ziprasidone | GRP-19577 | Capsule 60 mg (as hydrochloride) | Oral | Zeldox |
Ziprasidone | GRP-19576 | Capsule 80 mg (as hydrochloride) | Oral | Zeldox |
Zoledronic acid | GRP-17614 | Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL | Injection | APO-Zoledronic Acid |
Zoledronic acid | GRP-17612 | Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL | Injection | Aclasta |
Zolmitriptan | GRP-19573 | Tablet 2.5 mg | Oral | APO-Zolmitriptan |
Schedule 6—General statement for drugs for the treatment of hepatitis C
Note: See the definition of General statement for drugs for the treatment of hepatitis C in section 5.
1 Criteria for eligibility for drugs for the treatment of chronic hepatitis C
The criteria for patient eligibility for drugs for the treatment of chronic hepatitis C are that:
(a) the patient is treated by a medical practitioner or authorised nurse practitioner who:
(i) is experienced in the treatment of patients with chronic hepatitis C infection; or
(ii) is treating the patient in consultation with:
(A) a gastroenterologist; or
(B) a hepatologist; or
(C) an infectious diseases physician; and
(b) the patient has been assessed by the treating practitioner in accordance with clause 2.
For the purposes of paragraph 1(b), the patient has been assessed in accordance with this clause if the treating practitioner has:
(a) documented in the patient’s medical records:
(i) repeat test results showing the patient is antibody to hepatitis C virus (anti‑HCV) positive; and
(ii) a test result showing the patient is hepatitis C virus ribonucleic acid (RNA) positive; and
(iii) if known, evidence of the patient’s hepatitis C virus genotype; and
(b) chosen a treatment regimen listed for the patient in clause 3; and
(c) collected the following information:
(i) whether the patient is cirrhotic or non‑cirrhotic;
(ii) details of the previous treatment regimen, if the patient has previously failed a treatment with a regimen containing an NS5A inhibitor and the chosen treatment regimen is treatment with:
(A) sofosbuvir with velpatasvir and voxilaprevir; or
(B) glecaprevir with pibrentasvir.
For the purposes of paragraph 2(b), the treatment regimens for a kind of patient mentioned in column 1 of an item in the following table are the regimens listed in column 2 of the item.
Hepatitis C treatment regimens | ||
| Column 1 | Column 2 |
Item | Kind of patient | Treatment regimens |
1 | Patient: (a) with any genotype; and (b) who is treatment naïve; and (c) who is non‑cirrhotic | Either of the following: (a) sofosbuvir with velpatasvir for 12 weeks; (b) glecaprevir with pibrentasvir for 8 weeks |
2 | Patient: (a) with any genotype; and (b) who is treatment experienced; and (c) who is non‑cirrhotic | Any of the following: (a) sofosbuvir with velpatasvir for 12 weeks; (b) sofosbuvir with velpatasvir and voxilaprevir for 12 weeks; (c) glecaprevir with pibrentasvir for 8 weeks; (d) glecaprevir with pibrentasvir for 12 weeks; (e) glecaprevir with pibrentasvir for 16 weeks |
3 | Patient: (a) with Genotype 1; and (b) who is treatment naïve; and (c) who is non‑cirrhotic | Either of the following: (a) ledipasvir with sofosbuvir for 8 weeks; (b) ledipasvir with sofosbuvir for 12 weeks |
4 | Patient: (a) with Genotype 1; and (b) who is treatment experienced; and (c) who is non‑cirrhotic | Ledipasvir with sofosbuvir for 12 weeks |
5 | Patient: (a) with any genotype; and (b) who is treatment naïve; and (c) who is cirrhotic | Any of the following: (a) sofosbuvir with velpatasvir for 12 weeks; (b) glecaprevir with pibrentasvir for 8 weeks; (c) glecaprevir with pibrentasvir for 12 weeks |
6 | Patient: (a) with any genotype; and (b) who is treatment experienced; and (c) who is cirrhotic | Any of the following: (a) sofosbuvir with velpatasvir for 12 weeks; (b) sofosbuvir with velpatasvir and voxilaprevir for 12 weeks; (c) glecaprevir with pibrentasvir for 12 weeks; (d) glecaprevir with pibrentasvir for 16 weeks |
7 | Patient: (a) with Genotype 1; and (b) who is treatment naïve; and (c) who is cirrhotic | Ledipasvir with sofosbuvir for 12 weeks |
8 | Patient: (a) with Genotype 1; and (b) who is treatment experienced; and (c) who is cirrhotic | Ledipasvir with sofosbuvir for 24 weeks |
The endnotes provide information about this compilation and the compiled law.
The following endnotes are included in every compilation:
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history
Abbreviation key—Endnote 2
The abbreviation key sets out abbreviations that may be used in the endnotes.
Legislation history and amendment history—Endnotes 3 and 4
Amending laws are annotated in the legislation history and amendment history.
The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.
The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.
Editorial changes
The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.
If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.
Misdescribed amendments
A misdescribed amendment is an amendment that does not accurately describe how an amendment is to be made. If, despite the misdescription, the amendment can be given effect as intended, then the misdescribed amendment can be incorporated through an editorial change made under section 15V of the Legislation Act 2003.
If a misdescribed amendment cannot be given effect as intended, the amendment is not incorporated and “(md not incorp)” is added to the amendment history.
ad = added or inserted | o = order(s) |
am = amended | Ord = Ordinance |
amdt = amendment | orig = original |
c = clause(s) | par = paragraph(s)/subparagraph(s) |
C[x] = Compilation No. x | /sub‑subparagraph(s) |
Ch = Chapter(s) | pres = present |
def = definition(s) | prev = previous |
Dict = Dictionary | (prev…) = previously |
disallowed = disallowed by Parliament | Pt = Part(s) |
Div = Division(s) | r = regulation(s)/rule(s) |
ed = editorial change | reloc = relocated |
exp = expires/expired or ceases/ceased to have | renum = renumbered |
effect | rep = repealed |
F = Federal Register of Legislation | rs = repealed and substituted |
gaz = gazette | s = section(s)/subsection(s) |
LA = Legislation Act 2003 | Sch = Schedule(s) |
LIA = Legislative Instruments Act 2003 | Sdiv = Subdivision(s) |
(md) = misdescribed amendment can be given | SLI = Select Legislative Instrument |
effect | SR = Statutory Rules |
(md not incorp) = misdescribed amendment | Sub‑Ch = Sub‑Chapter(s) |
cannot be given effect | SubPt = Subpart(s) |
mod = modified/modification | underlining = whole or part not |
No. = Number(s) | commenced or to be commenced |
Name | Registration | Commencement | Application, saving and transitional provisions |
National Health (Listing of Pharmaceutical Benefits) Instrument 2024 (PB 26 of 2024) | 29 Mar 2024 (F2024L00426) | 1 Apr 2024 (s 2(1) item 1) |
|
National Health (Listing of Pharmaceutical Benefits) Amendment (May Update) Instrument 2024 (PB 39 of 2024) | 30 Apr 2024 (F2024L00498) | 1 May 2024 (s 2(1) item 1) | — |
National Health (Listing of Pharmaceutical Benefits) Amendment (June Update) Instrument 2024 (PB 52 of 2024) | 31 May 2024 (F2024L00603) | 1 June 2024 (s 2(1) item 1) | — |
National Health (Listing of Pharmaceutical Benefits) Amendment (July Update) Instrument 2024 (PB 68 of 2024) | 28 June 2024 (F2024L00825) | 1 July 2024 (s 2(1) item 1) | — |
Provision affected | How affected |
Part 1 |
|
s 2..................... | rep LA s 48D |
Schedule 1 |
|
Schedule 1................ | am F2024L00498; F2024L00603 (Sch 1 items 74, 76–78, 111 md not incorp); F2024L00825 (Sch 1 item 75 md not incorp) |
| ed C3 |
Schedule 3 |
|
Schedule 3................ | am F2024L00498; F2024L00603; F2024L00825 |
Schedule 4 |
|
Schedule 4................ | am F2024L00498 |
| ed C1 |
| am F2024L00603 (Sch 1 items 280, 281 md not incorp); F2024L00825 |
Schedule 5 |
|
Schedule 5................ | am F2024L00498 |
| ed C1 |
| am F2024L00603 (Sch 1 items 406, 407, 427, 431 (excluding the entry for Quetiapine in the form Tablet (modified release) 150 mg (as fumarate)) md not incorp); F2024L00825 (Sch 1 item 392 md not incorp) |
| ed C3 |
In preparing this compilation for registration, the following kinds of editorial change(s) were made under the Legislation Act 2003.
Kind of editorial change
Give effect to the misdescribed amendments as intended
Details of editorial change
Schedule 1 items 25, 26, 32, 43, 67, 68, 81, 90, 384, 394, 407, 419 and 421 of the National Health (Listing of Pharmaceutical Benefits) Amendment (July Update) Instrument 2024 (PB 68 of 2024) instruct to substitute the entry for a drug or form of a drug. However, multiple entries of these drugs or forms of drugs exist.
This compilation was editorially changed to substitute all entries for the drug or form of the drug listed in the table below to give effect to the misdescribed amendments as intended.
Schedule 1, Part 1 |
Buprenorphine with naloxone |
Calcium in the form Tablet, chewable, 500 mg (as carbonate) |
Cetuximab |
Dupilumab |
Methadone in the form Oral liquid containing methadone hydrochloride 25 mg per 5 mL in 1 L bottle, 1 mL |
Methadone in the form Oral liquid containing methadone hydrochloride 25 mg per 5 mL in 200 mL bottle, 1 mL |
Pantoprazole in the form Tablet (enteric coated) 40 mg (as sodium sesquihydrate) |
Sevelamer in the form Tablet containing sevelamer carbonate 800 mg |
Schedule 5 |
Amoxicillin with clavulanic acid |
Desvenlafaxine |
Octreotide |
Teriparatide |
Varenicline |